admt20200331

0001437749-20-015110.txt : 20200714 0001437749-20-015110.hdr.sgml : 20200714 20200714162425 ACCESSION NUMBER: 0001437749-20-015110 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 70 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200714 DATE AS OF CHANGE: 20200714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADM TRONICS UNLIMITED, INC. CENTRAL INDEX KEY: 0000849401 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 221896032 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17629 FILM NUMBER: 201027366 BUSINESS ADDRESS: STREET 1: 224 S PEGASUS AVE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017676040 MAIL ADDRESS: STREET 1: 224 S PEGASUS AVE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ADM TRONICS UNLIMITED INC/DE DATE OF NAME CHANGE: 19920703 10-K 1 admt20200331_10k.htm FORM 10-K admt20200331_10k.htm

FORM 10-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the fiscal year ended March 31, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from __________ to __________

COMMISSION FILE NUMBER 0-17629

ADM TRONICS UNLIMITED, INC.

(Name of registrant as specified in its charter)

Delaware	22-1896032
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

224 Pegasus Avenue, Northvale, New Jersey 07647

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number (201) 767-6040

SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT: None

SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:

COMMON STOCK, $.0005 PAR VALUE

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐ No ☒

The aggregate market value of voting stock held by non-affiliates of the registrant as of September 30, 2018, the last business day of the registrant’s most recently completed second fiscal quarter was $11,490,044.

The number of shares of the Common Stock outstanding as of July 14, 2020 was 67,588,492.

DOCUMENTS INCORPORATED BY REFERENCE

Not applicable.

FORWARD LOOKING STATEMENTS

This Annual Report on Form 10-K contains various forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and information that is based on management's beliefs as well as assumptions made by and information currently available to management. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. When used in this report, the words "anticipate," "believe," "estimate," "expect," "predict," "project" and similar expressions are intended to identify forward-looking statements. We cannot guarantee the accuracy of the forward-looking statements, and you should be aware that our actual results could differ materially from those contained in the forward-looking statements due to a number of factors, including the statements under "Risk Factors" set forth in "Item 1 - Description of Business" and the statements under "Critical Accounting Policies" set forth in "Item 6 - Management's Discussion and Analysis or Plan of Operation." Due to these uncertainties and risks, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K.

Unless otherwise indicated in this prospectus, references to "we," "us," "our" or the "Company" refer to ADM Tronics Unlimited, Inc. and its subsidiaries.

PART I

ITEM 1. BUSINESS

COMPANY OVERVIEW

The Company is a technology-based developer and manufacturer of diversified lines of products and derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; and, research, development, regulatory and engineering services.

The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary Sonotron Medical Systems, Inc. ("SMI").

COMPANY PRODUCTS AND SERVICES

ELECTRONICS FOR MEDICAL DEVICES AND OTHER APPLICATIONS

We develop and manufacture electronic technologies for non-invasive, electrotherapeutic and diagnostic medical devices as well as for veterinary and other applications. The products are manufactured at our Northvale facility which is an FDA-Registered Medical Device Manufacturing facility. We develop and manufacture our own proprietary products as well as on a contract basis for other companies.

CONTRACT MANUFACTURING

The Company derives revenues from contract manufacturing of electronic medical and other devices from non-affiliated customers. As of March 31, 2020, we had approximately $670,000 of back-log for electronic product orders.

ENVIRONMENTALLY SAFE CHEMICAL PRODUCTS FOR INDUSTRIAL USES

We develop, manufacture and sell chemical products to industrial users. Such products consist primarily of the following:

●

Water-based primers and adhesives;


	●	Water-based coatings and resins;

	●	Water-based chemical additives; and

●

Anti-static conductive paints, coating and other products.

Water-based primers and adhesives are chemical compounds used to bind different plastic films, metal foils and papers. Examples are the binding of polyethylene to polyester, nylon, vinyl, aluminum, polypropylene, paper and cellophane. Our water-based primers and adhesives are similar in function to solvent-based primers that are widely used to bind plastic films, papers and foils. Solvent-based systems have come under criticism since they have been found to be highly pollutant, dangerous to health and generally caustic in nature. Based upon our experience since 1969, including information furnished to us by certain of our customers, we believe that water-based systems have no known polluting effects and pose no known health hazards. There can, of course, be no assurance that any governmental restrictions will not be imposed on our water-based products or that such products will be accepted as replacements for solvent based products.

Water-based coatings and resins for the printing industry are used to impart properties to the printed substrate. Our coatings and resins can be used to coat printed material for glossy or aesthetic appeal to make such material virtually impervious to certain types of grease and to impart other characteristics required or desired for various products and specifications.

Certain of our water-based chemical additives are used to impart properties to inks and other chemical products used in the food packaging and printing industries. These additives are used for their ability to improve the performance of such products.

Through Anti-Static Industries, the assets of which were acquired in July 2009, we now develop and manufacture a full-line of anti-static products for commercial and industrial use through a division of our company that we refer to as “Antistatic Industries”. Antistatic Industries develops and distributes proprietary conductive paints, coatings and other products and accessories which can be used by electronics, computer, pharmaceutical and chemical companies to prevent, reduce or eliminate static electricity. Many industries are concerned with static electricity as it can be hazardous to personnel and damage corporate facilities, computers, electronic equipment and valuable parts. Antistatic Industries has a wide range of products including paints, hoses, garments, floor mats, rugs, strapping, tapes, hook-and-loop, adhesive products and many other specialized items, all with conductive properties. Antistatic Industries has also pioneered low volatile organic compound conductive and antistatic paint and coating formulations that can be used as replacements for paints and coatings made from hazardous solvents. Antistatic Industries seeks to continually develop new products through research and development for new and current customers to aid in their quest for maximum protection with less waste and rejects in their manufacturing processes by reducing or eliminating static electricity.

None of our chemical products are protected by patents, although the names of some of such products have been protected by trademarks. We do not believe that any such trademarks are material to our business. As of March 31, 2020, the dollar amount of backlog orders for our chemical products believed by us to be firm was not material.

MEDICAL AND COSMETIC PRODUCTS

The Company has developed several medical and cosmetic topical products. The Company’s proprietary water-based, adhesive and related topical formulations are used for maxillofacial prosthetic medical applications and for professional makeup applications primarily for special makeup effects for film, TV and theatrical productions.

RESEARCH, DEVELOPMENT, REGULATORY AND ENGINEERING SERVICES

The Company provides research, development, regulatory and engineering services to unaffiliated customers for the design, development and manufacturing of medical devices, electronics and other technologies and products (the “Engineering Services”). The Engineering Services are provided by the Company to customers both on a fee-for-services basis and on a project basis.

CUSTOMERS

During the year ended March 31, 2020, one customer accounted for 48% of our net revenue. During the year ended March 31, 2019, two customers accounted for 58% of our net revenue. As of March 31, 2020, three customers accounted for 83% of our accounts receivable. As of March 31, 2019, two customers represented 88% of our accounts receivable. The loss of these major customers could have a material impact on our operations and cash flow.

MARKETING AND DISTRIBUTION

A majority of our product sales are distributed to customers directly from our headquarters in Northvale, NJ. Customers place purchase orders with us and products are then shipped via common carrier delivery on a "FOB shipping point" basis. A portion of the sales are accomplished through distributors who place purchase orders with us for certain quantities of our products which are shipped by common carrier to the distributor's respective warehouses. These stocking distributors then ship product to the ultimate customer via common carrier from their inventory of our products. Our contract manufacturing customers place orders with us for certain quantities of their products they desire to have us manufacture, typically providing a deposit with each order. Engineering Services are provided through written agreements with customers both on a fee-for-services basis and a project basis.

MANUFACTURER AND SUPPLIERS

MANUFACTURER

ADM manufactures its electronic and chemical products and SMI and other customers’ electronic products at its facilities located in Northvale, New Jersey.

ADM warranties the products it manufactures for SMI against defects in material and workmanship for a period of 90 days after the completion of manufacture. After such 90-day period, ADM has agreed to provide repair services for the products at its customary hourly repair rate plus the cost of any parts, components or items necessary to repair the products.

Under contract manufacturing agreements, all inventions, patentable or otherwise, trade secrets, discoveries, ideas, writings, technology, know-how, improvements or other advances or findings relating to the entities' products and technologies shall be and become the exclusive proprietary and confidential information of such entity or any person to whom such entity may have assigned rights therein. ADM has no rights in any such proprietary or confidential information and is prohibited from using or disclosing any of such proprietary or confidential information for its own benefit or purposes, or for the benefit or purpose of any other person other than the entity without such entity's prior written consent. ADM has also agreed to cooperate with each entity in securing for it any patents, copyrights, trademarks or the like which it may seek to obtain in connection therewith. If ADM breaches any of the confidentiality agreements contained in the manufacturing agreement, or if these agreements are not sufficient to protect the entity's technology or are found to be unenforceable, the entity's competitors could acquire and use information that it considers to be our trade secrets and the entity may not be able to compete effectively.

Since ADM is the exclusive manufacturer of all of SMI's current and future products under the manufacturing agreement, if the operations of ADM are interrupted or if orders or orders of other customers of the Company exceed our manufacturing capabilities, we may not be able to deliver products on time and the entities may not be able to deliver their respective products to their respective customers on time. Under the terms of the manufacturing agreement, if ADM is unable to perform its obligations thereunder or is otherwise in breach of any provision thereof, SMI has the right, without penalty, to engage third parties to manufacture some or all of its products. In addition, if SMI elects to utilize a third-party manufacturer to supplement the manufacturing being completed by ADM, SMI has the right to require us to accept delivery of the products from these third-party manufacturers, finalize the manufacture of the products to the extent necessary to comply with FDA regulations and ensure that the design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process have been met.

As a manufacturer of medical devices, ADM is required to comply with quality requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the manufacturing process. In addition, our manufacturing facility is required to be registered as a medical device manufacturing facility with the FDA and is subject to inspection by the FDA. The Company has been registered by the FDA as a Registered Medical Device Establishment since 1988 allowing it to manufacture medical devices in accordance with procedures outlined in FDA regulations, which include quality control and related activities. Such registration is renewable annually and although we do not believe that the registration will fail to be renewed by the FDA, there can be no assurance of such renewal.

SUPPLIERS

We purchase the raw materials, parts, components and other items required to manufacture our products. We rely on a limited number of suppliers for such raw materials, parts, components and other items. Although there are many suppliers for each of these raw materials, parts, components and other items, we are dependent on a limited number of suppliers for many of the significant raw materials and components due to our customers’ requirements. We do not have any long-term or exclusive purchase commitments with any of our suppliers. The failure to maintain existing relationships with suppliers or to establish new relationships in the future could also negatively affect our ability to obtain raw materials and components used in the products in a timely manner. If we are unable to obtain ample supply of product from our existing suppliers or alternative sources of supply, we may be unable to satisfy orders which could reduce our revenues and adversely affect relationships with our customers. Accordingly, in order to satisfy its customers' needs, we have maintained an inventory ranging, in dollar amounts, from 15% to 30% of sales of chemical products in the form of either raw materials or finished goods.

RESEARCH AND DEVELOPMENT

During our fiscal years ended March 31, 2020 and 2019, research and development expenses with respect to company-sponsored research and development activities were $589,373 and $673,855, respectively. During such fiscal years, we did not expend any funds on customer-sponsored research and development activities with respect thereto, other than contracted research and development from engineering services customers.

COMPETITION

Our businesses are highly competitive and substantially all of our competitors possess greater experience, financial resources, operating history and marketing capabilities than us. Although we do not believe that there are one or more dominant competitors in such industries, there can be no assurance that we will be able to effectively compete with any or all of our competitors on the basis of price, service or otherwise. Competitors may be better able to withstand a change in conditions and throughout the economy as a whole. In addition, current and anticipated future consolidation among our competitors and customers may cause us to lose market share as well as put downward pressure on pricing. Furthermore, there is a trend in industry toward relocation of manufacturing facilities to lower-cost regions such as Asia. Such relocation may permit some of our competitors to lower their costs and improve their competitive position. If we do not compete successfully, our business, operating margins, financial condition, cash flows and profitability could be adversely affected.

Our results of operations depend, in part, on our ability to expand our product offerings. We are committed to remaining a competitive producer and believe that our portfolio of new or re-engineered products is strong. However, we may not be able to develop new products, re-engineer existing products successfully or bring them to be competitive, we may not be able to continue to attract and retain customers to which we sell our products.

INSURANCE

The Company may be exposed to potential product liability claims by those who use our products. Therefore, we maintain a general liability insurance policy, which includes aggregate product liability coverage of $3,000,000 for certain of our products. We believe that our present insurance coverage is adequate for the types of products we currently market. There can be no assurance, however, that such insurance will be sufficient to cover potential claims or that the present level of coverage will be available in the future at a reasonable cost.

ITEM 1A. RISK FACTORS

An investment in our stock involves a high degree of risk. You should carefully consider the following information, together with other information in this annual report, before buying shares of our stock. If any of the following risks or uncertainties occur, our business, financial condition and results of operations could be materially and adversely affected, the trading price of our stock could decline and you may lose all or a part of the money you paid to buy our stock.

RISKS RELATING TO OUR OPERATIONS

NEW ENVIRONMENTAL OR OTHER REGULATIONS COULD INCREASE THE COMPANY'S OPERATING COSTS.

Like other manufacturers, the Company is subject to a broad range of Federal, state and local laws and requirements, including those governing discharges in the air and water, the handling and disposal of solid and hazardous substances and wastes, the remediation of contamination associated with the release of hazardous substances, work place safety and equal employment opportunities. We have made expenditures to comply with such laws and requirements. We believe, based on information currently available to management, that we are in compliance with applicable environmental and other legal requirements and that we will not require material capital expenditures to maintain compliance with such requirements in the foreseeable future. Governmental authorities have the power to enforce compliance with such laws and regulations, and violators may be subject to penalties, injunctions or both. Third parties may also have the right to enforce compliance with such laws and regulations. As ADM develops new products, those products may become subject to additional review and approval requirements governing the sale and use of its products. Although our manufacturing processes do not currently result in the generation of hazardous wastes, this may not always be the case and material costs or liabilities may be incurred by us in the future as a result of the manufacturing operations. It is also possible that other developments, such as additional or increasingly strict requirements of laws and regulations of these types, or enforcement policies there under, could significantly increase our costs of operations.

BECAUSE WE USE VARIOUS MATERIALS AND SUBSTANCES IN MANUFACTURING OUR CHEMICAL PRODUCTS, OUR PRODUCTION FACILITIES ARE SUBJECT TO OPERATING HAZARDS THAT COULD CAUSE PERSONAL INJURY AND LOSS OF LIFE, SEVERE DAMAGE TO, OR DESTRUCTION OF, PROPERTY AND EQUIPMENT AND ENVIRONMENTAL CONTAMINATION.

We are dependent on the continued operation of our production and distribution facility. This facility is subject to hazards associated with the manufacture, handling, storage and transportation of chemical materials and products, including natural disasters, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, and environmental hazards, such as spills, discharges or releases of toxic or hazardous substances and remediation complications. These hazards can cause personal injury and loss of life, severe damage to, or destruction of, property and equipment and environmental contamination and other environmental damage and could have a material adverse effect on our financial condition. In addition, due to the nature of our business operations, we could become subject to scrutiny from environmental action groups.

FAILURE TO DEVELOP NEW CHEMICAL PRODUCTS AND/OR IMPROVE OUR EXISTING PRODUCTS WILL MAKE US LESS COMPETITIVE.

Our results of operations depend, in part, on our ability to expand our product offerings. We are committed to remaining a competitive producer and believe that our portfolio of new or re-engineered products is strong. However, we may not be able to continue to develop new products, re-engineer our existing products successfully or bring them to market in a timely manner. While we believe that the products, pricing and services we offer customers are competitive, we may not be able to continue to attract and retain customers to whom we sell our products.

FAILURE TO MAKE CONTINUED IMPROVEMENTS IN OUR PRODUCTIVITY COULD HURT OUR COMPETITIVE POSITION.

In order to obtain and maintain a competitive position, we believe that we must continue to make improvements in our productivity. When we invest in new technologies or processes, we face risks related to cost overruns and unanticipated technical difficulties. Our inability to anticipate, respond to or utilize changing technologies could have a material adverse effect on our business and our results of operations.

CHANGES IN OUR CUSTOMERS' PRODUCTS COULD REDUCE THE DEMAND FOR OUR CHEMICAL PRODUCTS, WHICH MAY DECREASE OUR NET SALES AND OPERATING MARGINS.

Our chemical products are used for a broad range of applications by our customers. Changes, including technological changes, in our customers' products or processes may make our chemical products unnecessary, which would reduce the demand for those products. Other customers may find alternative materials or processes that no longer require our products. If the demand for our chemical products is reduced, our net sales and operating margins may be reduced as well.

WE HAVE FEW PROPRIETARY RIGHTS WITH RESPECT TO OUR CHEMICAL PRODUCTS, THE LACK OF WHICH MAY MAKE IT EASIER FOR OUR COMPETITORS TO COMPETE AGAINST US.

None of our chemical products are protected by patents. We do attempt to protect the names of some of our chemical products through trademarks and some of our other limited proprietary property through trade secret, nondisclosure and confidentiality measures; however, such protections may not preclude competitors from developing similar technologies.

CUSTOMERS OUTSOURCE THE MANUFACTURING OF THEIR PRODUCTS TO US AND IF OUR OPERATIONS ARE INTERRUPTED OR IF OUR ORDERS EXCEED OUR MANUFACTURING CAPABILITIES, THEY MAY NOT BE ABLE TO DELIVER THEIR PRODUCTS TO CUSTOMERS ON TIME.

We operate a single facility and have limited capacity that may be inadequate if customers place orders for unexpectedly large quantities of products, or if our other customers place large orders of products. In addition, if our operations were halted or restricted, even temporarily, or we are unable to fulfill large orders, our customers could experience business interruption, increased costs, damage to their reputations and loss of their customers. Although customers have the right to utilize other manufacturers, such manufacturers of their products need to be licensed with the FDA, and identifying and qualifying a new manufacturer to replace us as the manufacturer of their products could take several months during which time, they would likely lose customers and our revenues could be materially delayed and/or reduced. In addition, our failure to produce such products could result in claims against us.

WE DEPEND ON A LIMITED NUMBER OF SUPPLIERS FOR THE COMPONENTS AND RAW MATERIALS USED IN OUR PRODUCTS AND THE PRODUCTS MANUFACTURED FOR THIRD PARTIES, AND ANY INTERRUPTION IN THE AVAILABILITY OF THESE COMPONENTS AND RAW MATERIALS COULD REDUCE OUR REVENUE.

We rely on a limited number of suppliers for the components and raw materials used in the products that we manufacture for others. Although there are many suppliers for each of the component parts and raw materials, we are dependent on a single or limited number of suppliers for many of the significant components and raw materials due to our customers’ specifications. This reliance involves a number of significant risks, including:

●	unavailability of materials and interruptions in delivery of components and raw materials from suppliers;
●	manufacturing delays caused by such unavailability or interruptions in delivery; and
●	fluctuations in the quality and the price of components and raw materials.

We do not have any long-term or exclusive purchase commitments with any of our suppliers. Failure to maintain existing relationships with suppliers or to establish new relationships in the future could also negatively affect our ability to obtain components and raw materials used in these products in a timely manner. If we are unable to obtain ample supply of product from existing suppliers or alternative sources of supply, we may be unable to satisfy our customers' orders which could reduce our revenues and adversely affect our relationships with these customers.

OUR ABILITY TO EXECUTE OUR BUSINESS PLAN DEPENDS ON THE SCOPE OF OUR INTELLECTUAL PROPERTY RIGHTS AND NOT INFRINGING THE INTELLECTUAL PROPERTY RIGHTS OF OTHERS. THE VALIDITY, ENFORCEABILITY AND COMMERCIAL VALUE OF THESE RIGHTS ARE HIGHLY UNCERTAIN.

Our ability to compete effectively with other companies is materially dependent upon the proprietary nature of our technologies. We rely primarily on patents and trade secrets to protect our products.

Third parties may seek to challenge, invalidate, circumvent or render unenforceable any patents or proprietary rights owned by us based on, among other things:

●	subsequently discovered prior act;
●	lack of entitlement to the priority of an earlier, related application; or
●	failure to comply with the written description, best mode, enablement or other applicable requirements.

In general, the patent position of medical device companies is highly uncertain, still evolving and involve complex legal, scientific and factual questions. We are at risk that:

●	other patents may be granted with respect to the patent applications filed by us; and
●	any patents issued to us may not provide commercial benefit to us or will be infringed, invalidated or circumvented by others.

The United States Patent and Trademark Office currently has a significant backlog of patent applications, and the approval or rejection of patents may take several years. Prior to actual issuance, the contents of United States patent applications are generally published 18 months after filing. Once issued, such a patent would constitute prior art from its filing date, which might predate the date of a patent application on which we rely. Conceivably, the issuance of such a prior art patent, or the discovery of "prior art" of which we are currently unaware, could invalidate a patent of ours or prevent commercialization of a product claimed thereby.

Although we generally conduct a cursory review of issued patents prior to engaging in research or development activities, we may be required to obtain a license from others to commercialize any of our new products under development. If patents that cover our existing or new products are issued to other companies, there can be no assurance that any necessary license could be obtained on favorable terms or at all.

There can be no assurance that we will not be required to resort to litigation to protect our patented technologies and other proprietary rights or that we will not be the subject of additional patent litigation to defend our existing and proposed products and processes against claims of patent infringement or any other intellectual property claims. Such litigation could result in substantial costs, diversion of management's attention, and diversion of our resources.

We also have applied for patent protection in several foreign countries. Because of the differences in patent laws and laws concerning proprietary rights between the United States and foreign countries, the extent of protection provided by patents and proprietary rights granted to us by the United States may differ from the protection provided by patents and proprietary rights granted to us by foreign countries.

We attempt to protect our trade secrets, including the processes, concepts, ideas and documentation associated with our technologies, through the use of confidentiality agreements and non-competition agreements with our current employees, and with other parties to whom we have divulged such trade secrets. If our employees or other parties breach our confidentiality agreements and non-competition agreements or if these agreements are not sufficient to protect our technology or are found to be unenforceable, our competitors could acquire and use information that we consider to be our trade secrets and we may not be able to compete effectively. Most of our competitors have substantially greater financial, marketing, technical and manufacturing resources than we have and we may not be profitable if our competitors are also able to take advantage of our trade secrets.

We may decide for business reasons to retain certain knowledge that we consider proprietary as confidential and elect to protect such information as a trade secret, as business confidential information or as know-how. In that event, we must rely upon trade secrets, know-how, confidentiality and non-disclosure agreements and continuing technological innovation to maintain our competitive position. There can be no assurance that others will not independently develop substantially equivalent proprietary information or otherwise gain access to or disclose such information.

IF THE FDA OR OTHER STATE OR FOREIGN AGENCIES IMPOSE REGULATIONS THAT AFFECT OUR MEDICAL DEVICE PRODUCTS, OUR DEVELOPMENT, MANUFACTURING AND MARKETING COSTS WILL BE INCREASED.

The testing and production of medical devices are subject to regulation by the FDA as devices under the 1976 Medical Device Amendments to the Federal Food, Drug and Cosmetic Act. In the United States, medical devices must be:

●	manufactured in registered and quality approved establishments by the FDA; and
●	produced in accordance with the FDA Quality System Regulation ("QSR") for medical devices.

As a result, we, as the manufacturer of other parties' devices, are required to comply with QSR requirements and if we fail to comply with these requirements, these other third parties will need to find another company to manufacture its devices. In addition, the Company's manufacturing facility:

●	is required to be registered as a medical device manufacturing facility with the FDA; and
●	is subject to inspection by the FDA.

The FDA can impose civil and criminal enforcement actions and other penalties on us if we fail to comply with stringent FDA regulations.

Medical device manufacturing facilities must maintain records, which are available for FDA inspectors documenting that the appropriate manufacturing procedures were followed. The FDA has authority to conduct inspections of our facility. Labeling and promotional activities are also subject to scrutiny by the FDA and, in certain instances, by the Federal Trade Commission. Any failure by us to take satisfactory corrective action in response to an adverse inspection or to comply with applicable FDA regulations could result in enforcement action against us, including a public warning letter, a shutdown of manufacturing operations, a recall of our products, civil or criminal penalties or other sanctions. From time to time, the FDA may modify such requirements, imposing additional or different requirements which may require us to alter our business methods which could result in increased expenses.

RISKS RELATED TO OUR COMPANY

At March 31, 2020, we had an accumulated deficit of approximately nearly $30 million. We may incur additional operating losses, as well as negative cash flows from operations, in the future.

We are highly dependent upon certain customers to generate our revenues. For the fiscal year ended March 31, 2020, one customer accounted for 48% of our net revenue. For the fiscal year ended March 31, 2019, two customers accounted for 58% of our net revenue. All customer purchases are made through purchase orders and we do not have any long-term contracts with customers. The complete loss of, or significant reduction in business from, or a material adverse change in the financial condition of, any of such customers will cause a material and adverse change in our revenues and operating results.

WE MAY BE EXPOSED TO POTENTIAL RISKS RELATING TO OUR INTERNAL CONTROL OVER FINANCIAL REPORTING AND OUR ABILITY TO HAVE THE OPERATING EFFECTIVENESS OF OUR INTERNAL CONTROLS ATTESTED TO BY OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

As directed by Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) the Securities and Exchange Commission (“SEC”) adopted rules requiring public companies to include a report of management on the company’s internal control over financial reporting in their annual reports on Form 10-K. A report of our management is included in our Annual Report on Form 10-K. We can provide no assurance that we will be able to comply with all of the requirements imposed thereby. In the event we identify significant deficiencies or material weaknesses in our internal control over financial reporting that we cannot remediate in a timely manner, investors and others may lose confidence in the reliability of our financial statements.

WE MAY BE EXPOSED TO PRODUCT LIABILITY CLAIMS FOR WHICH OUR INSURANCE MAY BE INADEQUATE.

Our business exposes us to potential product liability risks, which are inherent in the testing, manufacturing and marketing of chemical products and electronic devices. Although we maintain a general liability insurance policy, which includes aggregate product liability coverage of $3,000,000 for certain of our products, there can be no assurance, that such insurance will be sufficient to cover potential claims or that the present level of coverage will be available in the future at a reasonable cost.

While we are not aware of side-effects resulting from the use of any of our products, there may be unknown long-term effects of their use that may result in product liability claims in the future. Further, we cannot provide any assurance that:

●	our insurance will provide adequate coverage against potential liabilities if a product causes harm or fails to perform as promised;
●	adequate product liability insurance will continue to be available in the future; or
●	our insurance can be maintained on acceptable terms.

The obligation to pay any product liability claim in excess of whatever insurance we are able to obtain would increase our expenses and could greatly reduce our assets. See "Item 1. Business - Insurance."

THE LOSS OF ANY OF OUR EXECUTIVE OFFICER OR KEY PERSONNEL MAY ADVERSELY AFFECT OUR OPERATIONS AND OUR ABILITY TO EXECUTE OUR GROWTH STRATEGY.

Our ability to execute our business plan depends upon the continued services of Andre' DiMino, our President and Chief Executive Officer, as well as our key technology, marketing, sales and support personnel. In January 2013, the Company entered into an employment agreement with Mr. DiMino containing non-compete, confidentiality and other provisions for the benefit of the Company. However, such agreement has provisions for early termination by the Company and/or Mr. DiMino. We do not have employment or consulting agreements containing non-compete agreements with certain of our key personnel, and we may not be able to retain these individuals. If we lost the services of Mr. DiMino or our key personnel, our business may be adversely affected and our stock price may decline. In addition, our ability to execute our business plan is dependent on our ability to attract and retain additional highly skilled personnel.

OUR EXECUTIVE OFFICER AND ENTITIES AFFILIATED WITH HIM HAVE SUBSTANTIAL CONTROL OVER US, WHICH COULD DELAY OR PREVENT A CHANGE IN OUR CORPORATE CONTROL FAVORED BY OUR OTHER SHAREHOLDERS.

Our executive officer and director, Mr. DiMino, together with members of the DiMino family, and entities affiliated with them may be deemed to beneficially own, in the aggregate, approximately 38% of our outstanding common stock. The interests of our current officer and director shareholder may differ from the interests of our other shareholders. As a result, the current officer and director would have the ability to exercise substantial control over all corporate actions requiring shareholder approval, irrespective of how our other shareholders may vote, including the following actions:

●	the election of directors;
●	adoption of stock option plans;
●	the amendment of charter documents; or
●	the approval of certain mergers and other significant corporate transactions, including a sale of substantially all of our assets.

PENNY STOCK REGULATIONS MAY IMPOSE CERTAIN RESTRICTIONS ON MARKETABILITY OF OUR SECURITIES.

As of March 31, 2020, our common stock was exempt from the definition of a Penny Stock under SEC under Rule 240.3a51-1 because it meets one of the following tests: 1) A price of over $5 per share, 2) the issuer has Average Revenue of at least $6 million for the last 3 years, or 3) the issuer has Net Tangible Assets in excess of $2 million if the issuer has been in continuous operations for at least 3 years or $5 million if less than 3 years. Should we not meet one of the aforementioned requirements in the future, our common stock would be subject to penny stock rules. Penny stock rules, may discourage broker-dealers from effecting transactions in our common stock or affect their ability to sell our securities. As a result, purchasers and current holders of our securities could find it more difficult to sell their securities. Our stock is traded on the OTC Marketplace Venture Market referred to as the OTCQB. Trading volume of OTCQB stocks have been historically lower and more volatile then stocks traded on an exchange or the Nasdaq Stock Market. In addition, we may be subject to rules of the SEC that impose additional requirements on broker-dealers when selling penny stocks to persons other than established customers and accredited investors. In general, an accredited investor is a person with assets in excess of $1,000,000 or annual income exceeding $200,000 individually, or $300,000 together with his or her spouse. The relevant SEC regulations generally define penny stocks to include any equity security not traded on an exchange or the Nasdaq Stock Market with a market price (as defined in the regulations) of less than $5 per share. Under the penny stock regulations, a broker-dealer must make a special suitability determination as to the purchaser and must have the purchaser's prior written consent to the transaction. Prior to any transaction in a penny stock covered by these rules, a broker-dealer must deliver a disclosure schedule about the penny stock market prepared by the SEC. Broker-dealers must also make disclosure concerning commissions payable to both the broker-dealer and any registered representative and provide current quotations for the securities. Finally, broker-dealers are required to send monthly statements disclosing recent price information for the penny stock held in an account and information on the limited market in penny stocks.

OUR STOCK PRICE, LIKE THAT OF MANY SMALL COMPANIES, HAS BEEN AND MAY CONTINUE TO BE VOLATILE.

We expect that the market price of our common stock will fluctuate as a result of variations in our quarterly operating results and other factors beyond our control. These fluctuations may be exaggerated if the trading volume of our common stock is low.

WE HAVE NOT PAID DIVIDENDS IN THE PAST AND DO NOT EXPECT TO PAY DIVIDENDS IN THE FUTURE, AND ANY RETURN ON INVESTMENT MAY BE LIMITED TO THE VALUE OF YOUR STOCK.

We have never paid any cash dividends on our common stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future and any return on investment may be limited to the value of your stock. We plan to retain any future earnings to finance growth.

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable

ITEM 2. PROPERTIES

We are headquartered at 224 Pegasus Avenue, Northvale, New Jersey. We lease approximately 16,000 square feet of combined office and warehouse space from an unaffiliated third party with a monthly rent of $8,478 subject to certain increases. The lease expires in June 2028. The Company and its subsidiary utilize portions of the leased space.

We believe that our existing facilities are suitable as office, storage, laboratory and manufacturing space, and are adequate to meet our current needs. We further believe that such properties are adequately covered by insurance.

We do not own any real property for use in our operations or otherwise.

ITEM 3. LEGAL PROCEEDINGS

NONE

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

MARKET INFORMATION

The Company's common stock trades on the OTCQB Marketplace, operated by OTC Markets Group, Inc. under the symbol "ADMT."

The table below sets forth the high and low bid information for our common stock on the OTCQB Marketplace for the indicated periods and reflects inter-dealer prices, without retail mark-up, mark-down, or commission, and may not necessarily represent actual transactions.

Quarter Ended	High Bid		Low Bid

Fiscal 2020
31-Mar-20	$	0.16	$	0.12
31-Dec-19	$	0.20	$	0.20
30-Sep-19	$	0.19	$	0.17
30-Jun-19	$	0.15	$	0.12

Fiscal 2019
31-Mar-19	$	0.16	$	0.15
31-Dec-18	$	0.17	$	0.12
30-Sep-18	$	0.17	$	0.16
30-Jun-18	$	0.17	$	0.14

HOLDERS OF RECORD

As of March 31, 2020, 67,588,492 shares of the Company's common stock were issued and outstanding. On March 31, 2020, there were 1,319 shareholders of record.

DIVIDENDS

The Company has never paid any cash dividends on its common stock and has no intention of paying cash dividends in the foreseeable future. The Company intends to retain all earnings, if any, for use in the operation and expansion of its business.

EQUITY COMPENSATION PLAN

During the year end March 31, 2020, the company issued 300,000 shares of stock options to an employee.

ITEM 6. SELECTED FINANCIAL DATA.

Not Applicable

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-K to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item. 1 Description of Business – Risk Factors" and elsewhere in, or incorporated by reference into this Annual Report on Form 10-K.

CRITICAL ACCOUNTING POLICIES

REVENUE RECOGNITION

ELECTRONICS:

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90-day warranty on our electronics products and contract manufacturing and a limited 5-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have no other post shipment obligations. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for each of the fiscal years ended March 31, 2020 and 2019. For contract manufacturing, revenues are recognized after shipment of the completed products.

Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately $216,000 as of March 31, 2019 were recognized as revenues during the year ended March 31, 2020.

CHEMICAL PRODUCTS:

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

ENGINEERING SERVICES

We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services on a monthly basis over time as the applicable performance obligations are satisfied.

All revenue is recognized net of discounts.

ACCOUNTS RECEIVABLE

ADM extends credit terms to our customers based on their credit worthiness. As such, we record accounts receivable at the time of shipment, when our right to the consideration becomes unconditional. Accounts receivable from our customers are typically due within 30 days of invoicing. An allowance for doubtful accounts is provided based on a periodic analysis of individual account balances, including an evaluation of days outstanding, payment history, recent payment trends, and our assessment of our customers' creditworthiness.

USE OF ESTIMATES

Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to reserves, deferred tax assets and valuation allowance, impairment of long-lived assets, fair value of equity instruments issued to consultants for services and fair value of equity instruments issued to others. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above described items, are reasonable.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

Lease Accounting. In February 2016, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changes financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of April 1, 2019, using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) the initial direct costs for any existing leases. The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The adoption of this guidance had a material impact on the Company’s Condensed Consolidated Balance Sheet beginning April 1, 2019. Prior periods were not restated. See Notes 2 and 8 for further discussion of leases.

In June 2016, the FASB issued ASU2016-13 “Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are not accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after December 15, 2019, including interim periods with those fiscal years. The Company is evaluating the potential impact on the Company’s consolidated financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements.

BUSINESS OVERVIEW

ADM is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. During the years ended March 31, 2020 and 2019, our operations were conducted through ADM itself and its subsidiary, Sonotron.

We are a technology-based developer and manufacturer of diversified lines of products and services in the following areas: electronics for non-invasive medical and other applications; research, development, regulatory and engineering services; and, environmentally safe chemical products for industrial, cosmetic and topical uses.

REVENUES AND GROSS MARGINS

Revenues increased $467,038, or 15% from the prior year, which resulted from an increase in $670,284 of the electronic segment and $49,551 in the chemicals segment, offset by a decrease in $252,797 in the engineering segment. The decrease in engineering services was primarily the result of completion of several projects for one customer.

Engineering services revenues were also reduced due to the Company's decision to expend increased engineering resources on research and development activities of its proprietary medical devices in accordance with management's plan to expedite the commercialization of these technologies.

OPERATING (LOSS)

Loss from operations for the year ended March 31, 2020 was ($43,389). Loss from operations for the year ended March 31, 2019 was ($374,720), a decrease of $331,331 or 86%.

Selling, general and administrative expenses decreased by $237,657 or 19%, from $1,243,011 to $1,005,354, mainly due to a decrease of officer and administrative salaries of $137,000, decrease in consulting fees of approximately $68,000, and a decrease in legal fees of $16,000.

INCOME TAXES

During the fourth quarter of 2018, the Company calculated that it is entitled to federal and state research and development credits totaling approximately $429,000. This offset the increase in deferred income taxes due to the decrease in the federal corporate tax rates. During the current year, the Company received its estimate of federal research and development credits.

NET LOSS PER SHARE

Net (loss) for the fiscal years ended March 31, 2020 and 2019 was ($95,759) and ($342,579) or ($0.00) and ($0.01) per share, respectively.

LIQUIDITY AND CAPITAL RESOURCES

At March 31, 2020, we had cash and cash equivalents of $1,438,714 as compared to $1,555,687 at March 31, 2019. The decrease of $116,973 was primarily the result of cash provided in operations in the amount of $69,960, offset by cash used in investing activities of $14,860 and financing activities of $172,073. We expect to have enough cash to fund operations for the next twelve months.

Future Sources of Liquidity:

We expect our primary source of cash during fiscal 2020 to be net cash provided by operating activities. We expect that growth in profitable revenues and continued focus on new customers will enable us to continue to generate cash flows from operating activities.

If we do not generate sufficient cash from operations, face unanticipated cash needs or do not otherwise have sufficient cash, we have the ability to reduce certain expenses depending on the level of business operation.

Based on current expectations, we believe that our existing cash of $1,438,714 as of March 31, 2020 and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

Although we expect available funds and funds generated from our operations to be sufficient to meet our anticipated needs for a minimum of 12 months, we may need to obtain additional capital to continue to operate and grow our business. Our cash requirements may vary materially from those currently anticipated due to changes in our operations, including our marketing and sales activities, product development, and the timing of our receipt of revenues. As of March 31, 2020, we have $370,000 available for use through our line of credit. Our ability to obtain additional financing in the future will depend in part upon the prevailing capital market conditions, as well as our business performance. There can be no assurance that we will be successful in our efforts to arrange additional financing on terms satisfactory to us or at all. Additionally, we will continue to reduce certain of our expenses in order to assist in meeting our capital needs.

IMPACT OF THE COVID-19 PANDEMIC

The COVID-19 global pandemic has negatively affected the global economy. We began to see the impact of COVID-19 during our fourth quarter of fiscal 2020 with certain of our customers being required to close and/or suspend their own operations due to the COVID-19 pandemic. As a result, net sales and production levels during the fourth quarter of fiscal 2020 and the first quarter of fiscal 2021 were reduced, thus impacting our results of operations during these quarters. In May 2020, we received a loan of approximately $381,000 under the U.S. Small Business Administration Paycheck Protection Program, to assist with the economic hardships caused by the pandemic,

The extent of the impact of the COVID-19 pandemic on our business, financial results and liquidity will depend on future developments and the financial condition of our customers that we may not be able to foresee. Any of these factors, and other factors beyond our control, can adversely impact our results for the first quarter of fiscal 2021, as well as the full fiscal year, and such impact may be material.

OPERATING ACTIVITIES

Net cash used by operating activities was $69,960 for the fiscal year ended March 31, 2020. Cash provided during the year ended March 31, 2020 was primarily due to net loss of $95,759, write-off of inventories of $136,465 and an increase in reserve for bad debt of $65,000, off-set by decreases in deferred taxes of $88,000, a decrease in operating liabilities of $32,353, depreciation and amortization of $39,559, and an increase in net operating assets of $232,827.

Net cash used by operating activities was $275,543 for the fiscal year ended March 31, 2019. Cash provided during the year ended March 31, 2019 was primarily due to net loss of $342,579, write-off of inventories of $131,089 and an increase in reserve for bad debt of $35,000, off-set by decreases in deferred taxes of $15,000, an increase in operating liabilities of $197,839, depreciation and amortization of $39,055 and increases in net operating assets of $320,947.

INVESTING ACTIVITIES

For the fiscal year ended March 31, 2020, net cash used in investing activities was $14,860.

FINANCING ACTIVITIES

For the fiscal year ended March 31, 2020, net cash used in financing activities was $172,073, due to advances on the line of credit of $170,000 off-set by payments toward the line of credit of $309,885 and payments toward the capital lease of $32,188

For the fiscal year ended March 31, 2019, net cash used in financing activities was $28,874, due to repayment of the capital lease.

INFLATION

We believe our operations have not been and, in the foreseeable future, will not be materially and adversely affected by inflation or changing prices.

OFF-BALANCE SHEET ARRANGEMENTS

The Company has no off-balance sheet arrangements.

ITEM 7A. QUANTATATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

MARCH 31, 2020 AND 2019

I N D E X

	Page No.

Report of Independent Registered Public Accounting Firm	F-1

CONSOLIDATED FINANCIAL STATEMENTS:

Consolidated Balance Sheets as of March 31, 2020 and 2019	F-2

Consolidated Statements of Operations for the Years Ended March 31, 2020 and 2019	F-3

Consolidated Statements of Changes in Stockholders’ Equity for the Years Ended March 31, 2020 and 2019	F-4

Consolidated Statements of Cash Flows for the Years Ended March 31, 2020 and 2019	F-5

Notes to Consolidated Financial Statements	F-6

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and
Stockholders of ADM Tronics Unlimited, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of ADM Tronics Unlimited, Inc. and subsidiary (the "Company") as of March 31, 2020 and 2019, and the related consolidated statements of operations, changes in stockholders’ equity, and cash flows for each of the years in the two year period ended March 31, 2020, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2020 and 2019, and the results of its operations and its cash flows for each of the years in the two-year period ended March 31, 2020, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Adoption of New Accounting Standard

As discussed in Note 2 to the financial statements, the Company has changed its method of accounting for leases in the March 31, 2020 financial statements due to the adoption of Accounting Standards Update 2019-01, Leases (Topic 842), and the associated amendments, using the modified retrospective approach.

/s/ Raich Ende Malter & Co. LLP

We have served as the Company’s auditor since 2005.

Melville, New York

July 14, 2020

F-1

PART I. FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

	March 31,			March 31,
	2020			2019

ASSETS

Current assets:
Cash and cash equivalents	$	1,438,714		$	1,555,687
Accounts receivable, net of allowance for doubtful accounts of $225,000 and $160,000 at March 31, 2020 and 2019, respectively		860,539			916,844
Inventories		372,635			326,308
Prepaid expenses and other current assets		23,525			28,582

Total current assets		2,695,413			2,827,421

Other Assets:
Property and equipment, net of accumulated depreciation of $145,602 and $108,099 at March 31, 2020 and 2019, respectively		57,958			95,461
Right-of-use asset		706,307			-
Accounts receivable-related party		330,090			330,090
Inventories - long-term portion		132,080			85,457
Intangible assets, net of accumulated amortization of $14,093 and $12,035 at March 31, 2020 and 2019, respectively		21,703			8,899
Other assets		90,538			90,764
Deferred tax asset		1,019,000			1,107,000
Total other assets		2,357,676			1,717,671

Total assets	$	5,053,089		$	4,545,092

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Financing lease payable	$	21,458		$	31,196
Line of credit		30,000			169,885
Accounts payable		365,475			275,591
Accrued expenses and other current liabilities		136,188			150,549
Customer deposits		354,745			321,441
Due to stockholder		100,017			139,322
Total current liabilities		1,007,883			1,087,984

Long-term liabilities
Financing lease payable, net of current portion		-			22,450
Operating lease liability		706,307			-
Total long-term liabilities		706,307			22,450


Total liabilities	$	1,714,190		$	1,110,434

Stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding	$	-		$	-
Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,492 shares issued and outstanding		33,794			33,794
Additional paid-in capital		33,294,069			33,294,069
Accumulated deficit		(29,988,964	)		(29,893,205	)
Total stockholders' equity		3,338,899			3,434,658

Total liabilities and stockholders' equity	$	5,053,089		$	4,545,092

The accompanying notes are an integral part of these

consolidated financial statements.

F-2

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED MARCH 31, 2020 AND 2019

	2020			2019

Net revenues	$	3,485,992		$	3,018,954

Cost of sales		1,911,972			1,454,700

Gross Profit		1,574,020			1,564,254

Operating expenses:
Research and development		589,373			673,855
Selling, general and administrative		1,005,354			1,243,011
Depreciation and amortization		22,682			22,108

Total operating expenses		1,617,409			1,938,974

Loss from operations		(43,389	)		(374,720	)

Other income (expense):
Interest income		25,576			26,948
Interest expense		(8,424	)		(8,807	)
Total other income (expense)		17,152			18,141

(Loss) before benefit from income taxes		(26,237	)		(356,579	)

Benefit from income taxes:
Current		(18,478	)		(1,000	)
Deferred		88,000			15,000

Total benefit from income taxes		69,522			14,000

Net (loss)	$	(95,759	)	$	(342,579	)

Basic and diluted earnings per common share:	$	(0.00	)	$	(0.01	)

Weighted average shares of common stock outstanding - basic		67,588,492			67,588,492

Weighted average shares of common stock outstanding - diluted		67,588,492			67,588,492

The accompanying notes are an integral part of these

consolidated financial statements.

F-3

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE YEARS ENDED MARCH 31, 2020 AND 2019

	Common Stock Shares		Common Stock Amount		Additional Paid-in Capital		Accumulated Deficit			Total
Balance at March 31, 2018		67,588,492	$	33,794	$	33,294,069	$	(29,550,626	)	$	3,777,237

Net (loss)		-		-		-		(342,579	)		(342,579	)

Balance at March 31, 2019		67,588,492	$	33,794	$	33,294,069	$	(29,893,205	)	$	3,434,658


Net (loss)		-		-		-		(95,759	)		(95,759	)

Balance at March 31, 2020		67,588,492	$	33,794	$	33,294,069	$	(29,988,964	)	$	3,338,899

The accompanying notes are an integral part of these

consolidated financial statements.

F-4

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED MARCH 31, 2020 AND 2019

	2020			2019
Cash flows from operating activities:
Net (loss)	$	(95,759	)	$	(342,579
Adjustments to reconcile net income (loss) to net cash (used in) operating activities:
Depreciation and amortization		39,559			39,055
Write-off of inventories		136,465			131,089
Bad debt		65,000			35,000
Deferred taxes		88,000			(15,000	)
Non-cash operating lease expense		64,792			-
Non-cash interest expense		37,083			-
(Increase) decrease in operating assets:
Accounts receivable		(8,695	)		(74,441	)
Inventories		(229,415	)		(230,780	)
Prepaid expenses and other current assets		5,283			(15,726	)
(Increase) decrease in operating liabilities:
Accounts payable		89,884			(11,373	)
Customer deposits		33,304			199,274
Accrued expenses and other current liabilities		(14,361	)		1,167
Due to stockholder		(39,305	)		8,771
Payments of operating lease liability		(101,875	)		-

Net cash provided by (used in) operating activities		69,960			(275,543	)

Cash flows from investing activities:
Purchase of patents		(14,860	)		-

Net cash (used in) investing activities		(14,860	)		-

Cash flows from financing activities:
Proceeds from line of credit		170,000			386,000
Repayments of line of credit		(309,885	)		(216,115	)
Repayments of financing lease payable		(32,188	)		(32,187	)

Net cash provided by (used in) financing activities		(172,073	)		137,698

Net (decrease) in cash and cash equivalents		(116,973	)		(137,845	)

Cash and cash equivalents - beginning of year		1,555,687			1,693,532

Cash and cash equivalents - end of year	$	1,438,714		$	1,555,687


Cash paid for:
Interest	$	8,424		$	8,807
Non-cash operating activities:
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842	$	771,098		$	-

The accompanying notes are an integral part of these

consolidated financial statements.

F-5

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2020 AND 2019

NOTE 1 – NATURE OF BUSINESS

ADM Tronics Unlimited, Inc. ("we", "us", "the Company" or "ADM"), was incorporated under the laws of the state of Delaware on November 24, 1969. We are a manufacturing and engineering concern whose principal lines of business are the design, manufacture and sale of electronics of our own products or on a contract manufacturing basis; the production and sale of chemical and antistatic products; and, research, development and engineering services.

Electronic equipment is manufactured in accordance with customer specifications on a contract basis. Our electronic device product line consists principally of proprietary devices used in diagnostics and therapeutics of humans and animals and electronic controllers for spas and hot tubs. These products are sold to customers located principally in the United States. We are registered with the FDA as a contract manufacturing facility and we manufacture medical devices for customers in accordance with their designs and specifications. Our chemical product line is principally comprised of water-based chemical products used in the food packaging and converting industries, and anti-static conductive paints, coatings and other products. These products are sold to customers located in the United States, Australia, Asia and Europe. We also provide research, development, regulatory and engineering services to customers. Our Sonotron Medical Systems, Inc. subsidiary (“Sonotron”) is involved in medical electronic therapeutic technology.

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its wholly owned subsidiary Sonotron (the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

USE OF ESTIMATES

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our deferred tax assets and related valuation allowance, write down of inventory, impairment of long-lived assets, allowance for doubtful accounts, and warranty reserves. Actual amounts could differ from those estimates.

FAIR VALUE OF FINANCIAL INSTRUMENTS

For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.

CASH AND CASH EQUIVALENTS

Cash equivalents are comprised of certain highly liquid investments with original maturities of three months or less when purchased. We maintain our cash in bank deposit accounts, which at times, may exceed federally insured limits. We have not experienced any losses to date as a result of this policy. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of $250,000 per institution. At March 31, 2020, approximately $1,293,000 exceeded the FDIC limit.

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The carrying amounts of accounts receivable is reduced by a valuation allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will not be collected. Management provides for probable uncollectible amounts through a charge to expenses and a credit to a valuation allowance, based on its assessment of the current status of individual accounts. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable. Allowance for doubtful accounts was increased for the fiscal year ended March 31, 2020 to $225,000, compared to $160,000 at March 31, 2019.

F-6

REVENUE RECOGNITION

ELECTRONICS:

CHEMICAL PRODUCTS:

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

ENGINEERING SERVICES

All revenue is recognized net of discounts.

WARRANTY LIABILITIES

The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that no warranty liability is required as of the consolidated balance sheet dates. However, the Company periodically reviews the adequacy of its product warranties and will record an accrued warranty reserve if necessary.

INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) and net realizable value. Inventories that are expected to be sold within one operating cycle (1 year) are classified as a current asset. Inventories that are not expected to be sold within 1 year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off annually based on prior and expected future usage.

PROPERTY AND EQUIPMENT

We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over five to seven years, the estimated useful lives of the property and equipment.

INTANGIBLE ASSETS

Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount may not be recoverable. In reviewing for impairment, the Company compares the carrying value of the relevant asset to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and its carrying value.

ADVERTISING COSTS

Advertising costs are expensed as incurred and amounted to $41,353 and $59,877 for the fiscal years ended March 31, 2020 and 2019, respectively.

F-7

SHIPPING AND HANDLING COSTS

Shipping and handling costs incurred for the years ended March 31, 2020 and 2019 were approximately $3,153 and $3,754, respectively. Such costs are included in selling, general, and administrative expenses in the accompanying consolidated statements of operations.

INCOME TAXES

We report the results of our operations as part of a consolidated Federal tax return with our subsidiary. Deferred income taxes result primarily from temporary differences between financial and tax reporting. Deferred tax assets and liabilities are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates. A valuation allowance is recorded to reduce a deferred tax asset to that portion that is expected to more likely than not be realized.

The Company has adopted the authoritative accounting guidance with respect to accounting for uncertainty in income taxes, which clarified the accounting and disclosures for uncertain tax positions related to income taxes recognized in the consolidated financial statements and addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended March 31, as follows:

Jurisdiction	Fiscal Year
Federal	2015 and beyond
New Jersey	2014 and beyond

There are currently no tax years under examination by any major tax jurisdictions.

The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of March 31, 2020, and 2019, the Company has no accrued interest or penalties related to uncertain tax positions.

NET EARNINGS PER SHARE

We compute basic earnings per share by dividing net income/loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. Common equivalent shares are excluded from the computation of net earnings per share if their effect is anti-dilutive.

Per share basic and diluted (loss) amounted to ($0.00) and $(0.01) for the fiscal years ended March 31, 2020 and 2019, respectively.

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current year presentation.

RECENT ACCOUNTING PRONOUNCEMENTS

The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of twelve months or less and does not contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred.

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning April 1, 2019 when the Company recognized (a) a lease liability of $771,098, which represents the present value of the remaining lease payments of $967,344, discounted using the Company's incremental borrowing rate of 5% and (b) the related right-of-use asset of $771,098 which represents the lease liability. Prior periods were not restated. Adoption of this standard had no change on financing leases previously subject to capital lease treatment under ASC Topic 840, Leases. See Note 8 for further discussion of leases.

F-8

In June 2016, the FASB issued ASU-2016-13 “Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are not accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after December 15, 2019. The Company is evaluating the potential impact on the Company’s consolidated financial statements.

NOTE 3 - INVENTORIES

Inventories at March 31, 2020 consisted of the following:

	Current		Long Term		Total
Raw materials	$	289,369	$	121,013	$	410,382
Finished goods		83,266		11,067		94,333
Totals	$	372,635	$	132,080	$	504,715

Inventories at March 31, 2019 consisted of the following:

	Current		Long Term		Total
Raw materials	$	273,039	$	84,721	$	357,760
Finished goods		53,269		736		54,005
Totals	$	326,308	$	85,457	$	411,765

NOTE 4 - PROPERTY AND EQUIPMENT

Property and equipment as of March 31, 2020 and 2019 is as follows:

	2020			2019
Machinery and equipment	$	199,810		$	199,810
Leasehold improvements		3,750			3,750
		203,560			203,560

Accumulated depreciation and amortization		(145,602	)		(108,099	)

Property and equipment, net	$	57,958		$	95,461

Depreciation and amortization expense related to property and equipment amounted to $37,503 and $37,659 for the years ended March 31, 2020 and 2019, respectively.

F-9

NOTE 5 - INTANGIBLE ASSETS

Intangible assets are being amortized using the straight-line method over periods ranging from 10-15 years with a weighted average remaining life of approximately 6 years.

March 31, 2020

March 31, 2019

Cost

Accumulated

Amortization

Net

Carrying

Amount

Amortization

Period

(Years)

Cost

Accumulated

Amortization

Net

Carrying

Amount

Amortization

Period

(Years)

Patents & Trademarks

35,794

(14,091

)

21,703

20,934

(12,035

)

8,899

Amortization expense was $2,056 for each of the years ended March 31, 2020 and 2019.

Estimated aggregate future amortization expense related to intangible assets is as follows:

For the fiscal years ended March 31,
2021	$	2,882
2022		2,882
2023		2,882
2024		2,882
2025		2,465
Thereafter		7,710
	$	21,703

NOTE 6 – ACCOUNTS RECEIVABLE - RELATED PARTY

The Company has a $75,000 investment for 23.2% of Qol Devices Inc. (Qol), which is carried at cost and reported as a component of other assets in the accompanying consolidated balance sheets.

The Company provided $330,090 in engineering services to Qol during the year March 31, 2018. Qol owes the Company $330,090 as of March 31, 2020.

NOTE 7 – LINE OF CREDIT

On June 15, 2018, the Company obtained an unsecured revolving line of credit, with a limit of $400,000. The line expires May 15, 2021, renewing automatically every year. The Company is required to make monthly interest payments, at a rate of 5.37%. Any unpaid principal will be due upon maturity. As of March 31, 2020 and 2019, the outstanding balance was $30,000 and $169,885, respectively.

F-10

NOTE 8 – LEASES

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on June 30, 2028. The Company The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of March 31, 2020:

For the Years Ending March 31,
2021	$	101,875
2022		101,875
2023		101,875
2024		105,625
2025		106,875
Thereafter		347,344
		865,469
Less: Amount attributable to imputed interest		(159,161	)
Net liability at March 31, 2020	$	706,307

Weighted average remaining lease term (in years)		8.3
Weighted average discount rate		5.00	%

Rent and real estate tax expense for all facilities for the years ended March 31, 2020 and 2019 was approximately $135,000 and $132,000, respectively, and are reported as a component of cost of sales and selling, general and administrative expenses in the accompanying statement of operations. The Company paid in $101,875 in lease payments during the year.

During September 2016 the Company leased equipment with a cost of approximately $129,000, under provisions of various long-term financing leases whereby the minimum lease payments have been capitalized. Accumulated depreciation at March 31, 2020 is approximately $88,000. The leases expire over various years through 2021. Depreciation of the leased assets is included in depreciation and amortization expense. The lease obligations are secured by the leased assets.

Future minimum lease payments under the above financing leases, as of March 31, 2020, are approximately as follows:

For the Years Ending March 31,
2021	$	23,000
Less: Amount attributable to imputed interest		2,000

Present value of minimum lease payments		21,000
Less: Current maturities		21,000

	$	-

NOTE 9 – CONCENTRATIONS

During the year ended March 31, 2020, one customer accounted for 48% of our net revenue. During the year ended March 31, 2019, two customers accounted for 58% of our net revenues. As of March 31, 2020, three customers accounted for 83% of our accounts receivable. As of March 31, 2019, two customers accounted for 88% of our accounts receivable. The loss of these major customers could have a material impact on our operations and cash flow.

The Company’s customer base is comprised of foreign and domestic entities with diverse demographics. Revenues from foreign customers represented $324,596 of our net revenue or 9% for the year ended March 31, 2020. Revenues from foreign customers represented $364,418 of net revenues or 12% for the year ended March 31, 2019.

NOTE 10 - SEGMENT INFORMATION

Information about segments is as follows:

	Chemical			Electronics			Engineering		Total
Year ended March 31, 2020
Revenue from external customers	$	1,368,365		$	1,400,918		$	716,709	$	3,485,992
Segment operating income (loss)	$	58,477		$	(147,023	)	$	45,157	$	(43,389	)

Year ended March 31, 2019
Revenue from external customers	$	1,318,814		$	730,634		$	969,506	$	3,018,954
Segment operating income (loss)	$	(81,849	)	$	(403,099	)	$	110,228	$	(374,720	)


Total assets at March 31, 2020	$	5,053,89		$	1,970,705		$	1,061,149	$	5,053,089

Total assets at March 31, 2019	$	1,985,501		$	1,099,983		$	1,459,608	$	4,545,092

F-11

NOTE 11 - DISAGGREGATED NET REVENUES AND SEGMENT INFORMATION

The following tables show the Company's net revenues disaggregated by reportable segment and by product and service type:

	Twelve Months Ended March 31,
	2020		2019
Net Revenue in the US
Chemical	$	1,043,769	$	954,396
Electronics		1,400,918		730,634
Engineering		716,709		969,506
		3,161,396		2,654,536

Net Revenue outside the US
Chemical		324,596		364,418
Electronics		-		-
Engineering		-		-
		324,596		364,418

Total Revenues	$	3,485,992	$	3,018,954

NOTE 12 - INCOME TAXES

At March 31, 2020, the Company had federal and state net operating loss carry-forwards, (NOL’s) of approximately $2,468,000, which are due to expire through fiscal 2034. These NOLs may be used to offset future taxable income through their respective expiration dates and thereby reduce or eliminate our federal and state income taxes otherwise payable. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Ultimate utilization of such NOL’s and credits is dependent upon the Company’s ability to generate taxable income in future periods and may be significantly curtailed if a significant change in ownership occurs.

Significant components of deferred tax assets are as follows as of March 31, 2020 and 2019:

	2020		2019

Net operating loss carry-forward	$	536,000	$	637,000
Research & development tax credit carry-forward		429,000		429,000
Other		54,000		41,000

Deferred tax asset, net	$	1,019,000	$	1,107,000

The benefit from (provision) for income taxes for the years ended at March 31, 2020 and 2019 differs from that amount using the statutory federal income tax rate as follows:

	2020		2019

Statutory federal income tax rate		21%		21%
State Taxes, net of federal		7%		-
Other		(-228%)		(17%)
Effective income tax rate		(200%)		4%

F-12

NOTE 13 – STOCK BASED COMPENSATION

On September 2, 2015, ADM granted 3,000,000 stock options to employees at an exercise price of $0.20 per option and with a term of three years. The options were valued at $598,699 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 2.03%, volatility of 353%, estimated useful life of 3 years and dividend rate of 0%. The options expired during the year ended March 31, 2019.

On January 13, 2020, ADM granted 300,000 stock options to one employee at an exercise price of $0.20 per option with a term of two years subject to vesting in four equal amounts of 75,000 share every six months. The options were valued at $35,206 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 1.58%, volatility of 132%, estimated useful life of 3 years and dividend rate of 0%.

The following table summarizes information on all common share purchase options issued by us as of March 31, 2020 and 2019.

	2020				2019
	# of Shares		Weighted		# of Shares			Weighted
			Average					Average
			Exercise					Exercise
			Price					Price

Outstanding, beginning of year		-	$	-		3,000,000		$	0.20

Issued		300,000		0.20		-			-

Exercised		-		-		-			-

Expired		-		-		(3,000,000	)		-

Outstanding, end of year		300,000	$	0.20		-			-

Exercisable, end of year		-	$	-		-			-

As of March 31, 2020, there was $35,206 of unrecognized compensation costs, which is expected to be recognized as follows:

For the years ending March 31,	Amount
2021	$	11,735
2022		11,735
2023		11,736
	$	35,206

F-13

NOTE 14 – LEGAL PROCEEDINGS

In November 2019, the Company filed a civil suit in the Superior Court of New Jersey against an accounting firm seeking a declaratory judgement from the court that no sum is due to the accounting firm, plus damages, attorney's fees and costs with respect to the foregoing. This matter was settled by mutual agreement for the Company to pay $7,500 to the defendant. All claims were dismissed by both parties on June 2, 2020.

We are involved, from time to time, in litigation and proceedings arising out of the ordinary course of business. Other than the foregoing, there are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject.

NOTE 15 – SUBSEQUENT EVENTS

The World Health Organization characterized the COVID-19 virus as a global pandemic on March 11, 2020. The COVID-19 global pandemic has negatively affected the global economy. We began to see the impact of COVID-19 during our fourth quarter of fiscal 2020 with certain of our customers being required to close and/or suspend their own operations due to the COVID-19 pandemic. As a result, net sales and production levels during the fourth quarter of fiscal 2020 and the first quarter of fiscal 2021 were reduced, thus impacting our results of operations during these quarters. The extent of the impact of the COVID-19 pandemic on our business, financial results and liquidity will depend on future developments and the financial condition of our customers that we may not be able to foresee. Any of these factors, and other factors beyond our control, can adversely impact our results for the first quarter of fiscal 2021, as well as the full fiscal year, and such impact may be material. At this time, management is unable to quantify its potential effects on the operations and financial performance of the Company.

In May 2020, under the U.S. Small Business Administration Paycheck Protection Program, the Company received approximately $381,000. The loan will be forgiven if the funds are used for payroll costs, interest on mortgages, rent and utilities, with at least 60% being used for payroll. Forgiveness will be reduced if full-time headcount declines, or if salaries and wages decrease. Loan payments will also be deferred for six months. No collateral or personal guarantees were required for the loan. The loan has an interest rate of 1% and a maturity of two years, which can be extended up to five years if the Company and the lender agree.

We evaluated all subsequent events from the date of the consolidated balance sheet through the issuance date of these consolidated financial statements and determined that there are no events or transactions occurring during the subsequent event reporting period which require recognition or disclosure in the consolidated financial statements.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

None.

ITEM 9A. CONTROLS AND PROCEDURES

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES.

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d - 15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management necessarily applies its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding management's control objectives.

As of the end of the period covered by this Annual Report on Form 10-K, we carried out an evaluation, with the participation of management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based on that evaluation as of March 31, 2016, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective.

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Management is responsible for establishing and maintaining effective internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) over our company. Internal control over financial reporting is a process to provide reasonable assurance regarding the reliability of our financial reporting for external purposes in accordance with accounting principles generally accepted in the United States. Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our financial statements would be prevented or detected.

F-14

Management, including our Chief Executive Officer and Chief Financial Officer, has evaluated our internal control over financial reporting as of March 31, 2020, based on the framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission. Based on its assessment, management has concluded that our internal control over financial reporting was not effective as of March 31, 2020.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management’s report in this annual report.

The determination that our disclosure controls and procedures were not effective as of March 31, 2020 are a result of:

a. Deficiencies in Internal Control Structure Environment. During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.

b. Inadequate staffing and supervision within the accounting operations of our company. The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews. The Company’s plan is to expand its accounting operations as the business of the Company expands.

The Company believes that the financial statements fairly present, in all material respects, the Company’s consolidated balance sheets as of March 31, 2020 and 2019 and the related consolidated statements of operations, stockholders’ equity (deficiency), and cash flows for the years ended March 31, 2020 and 2019, in accordance with generally accepted accounting principles, notwithstanding the material weaknesses we identified.

INTERNAL CONTROL OVER FINANCIAL REPORTING.

There were no changes in the Company's internal control over financial reporting that occurred during the Company's last fiscal quarter of the fiscal year to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

The following table sets forth the name, position and age of the Company's sole executive officer and director. The Company's director serves until the next annual meeting of stockholders or until no successors is elected and qualified. Officers are elected by the board of directors and their terms of offices are, except to the extent governed by employment contracts, at the discretion of the board of directors.

Name	Age	Position
Andre' DiMino	64	President, Chief Executive Officer
		Chief Financial Officer, Director

Andre' DiMino has served as President of the Company since December 2001 and a director and Chief Financial Officer of the Company since 1987. Prior thereto, Mr. DiMino served as Executive Vice President and Chief Operating Officer since 1991 and Secretary and Treasurer of the Company since 1978. Mr. DiMino also served as the Technical Director of ADM Tronics from 1982 to 1991. Mr. DiMino served as Vice Chairman, Executive Vice President and Chief Technology officer of ITI from August 2008 to February 2010. He also served as Vice Chairman and Co-Chief Executive Officer of ITI from October 2006 to August 2008, and as Chairman and Chief Financial Officer from January 2004 until October 2006 and served as President of ITI from 1989 to January 2004. Since February 12, 2010, Mr. DiMino has served as Vice President-Engineering, Manufacturing and Regulatory for IHS.

AUDIT COMMITTEE AND AUDIT COMMITTEE FINANCIAL EXPERT

Although the Company is engaged in ongoing efforts to engage qualified board members, the Company does not have a separately designated audit committee or compensation committee at this time. Accordingly, the Company's Board of Directors also has determined that the Company does not have an audit committee financial expert. The Company continues to seek new board members in order to appoint a separately designated audit committee. The functions which would be performed by an audit committee are performed by the Board of Directors as a whole.

DIRECTOR INDEPENDENCE

We currently do not have any independent directors.

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Exchange Act, and the rules and regulations of the Securities and Exchange Commission promulgated there under, requires the Company's directors, executive officers and persons who own beneficially more than 10% of the Company's common stock to file reports of ownership and changes in ownership of such stock with the SEC. Based solely upon a review of such reports, the Company believes that all of its directors, executive officers and 10% stockholders complied with all applicable Section 16(a) filing requirements during the Company's last fiscal year.

CODE OF ETHICS

The Company has adopted a code of ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of such Code of Ethics has been filed as Exhibit 14.1 to the Annual Report on Form 10-KSB for the fiscal year ended March 31, 2005.

ITEM 11. EXECUTIVE COMPENSATION

Name and Principal Position	Year	Salary		Bonus		Option		Other		Total

Andre' DiMino, Chief Executive Officer	2020	$	150,020	$	15,002		-		-	$	165,022

	2019	$	150,020	$	15,002		-		-	$	165,022

EMPLOYMENT AGREEMENT

On January 10, 2013, we entered into an employment agreement with Andre’ DiMino to secure his continued service as President, and Chief Executive Officer (the “Employment Agreement”). The Employment Agreement has a ten-year term which will be automatically extended prior to the end of the then current term for successive one-year periods until either the Company or Mr. DiMino notifies the other at least 120 days prior to the end of the term that such party does not wish to further extend it. The Employment Agreement provides for a minimum annual salary of $125,000 and a fixed annual bonus equal to 10% of such annual salary, discretionary annual cash bonuses and participation on generally applicable terms and conditions in other compensation and fringe benefit plans. Mr. DiMino's employment agreement requires Mr. DiMino to devote at least a majority of his work-time toward the Company. The Employment Agreement provides that Mr. DiMino will be entitled to severance benefits in the amount of his base salary for a period of 12 months following the date of termination if his employment is terminated without cause or if he resigns for good reason, or 18 months following the date of termination if his employment is terminated without cause or if he resigns for good reason within 12 months following a change in control, in each case subject to the execution and delivery to the Company by Mr. DiMino of a general release.

During the term of the Employment Agreement and for a period of 12 months thereafter, subject to applicable law, Mr. DiMino will be subject to restrictions on competition with the Company and restrictions on the solicitation of the Company’s customers and employees. For all periods during and after the term, Mr. DiMino will be subject to nondisclosure and confidentiality restrictions relating to the Company’s confidential information and trade secrets and is obligated to assign all developments, related to the Company’s business, research and development activities, to the Company.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED

DIRECTORS' COMPENSATION

The Company does not pay fees to its directors, nor does it reimburse its directors for expenses incurred.

STOCKHOLDER MATTERS:

The following table sets forth information regarding ownership of shares of Company’s common stock, as of March 31, 2017, by (i) each person known to ADM to be the owner of 5% or more of ADM’s common stock (ii) each director and director nominee of ADM, (iii) the Named Officer, and (iv) all directors and officers of ADM as a group. Except as otherwise indicated, each person and each group shown in the table has sole voting and investment power with respect to the shares of the Company’s common stock indicated. For purposes of the table below, in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended, a person is deemed to be the beneficial owner, for purposes of any shares of Common Stock over which he or she has or shares, directly or indirectly, voting or investment power; or of which he or she has the right to acquire beneficial ownership at any time within 60 days after March 31, 2019. As used herein, “voting power” is the power to vote or direct the voting of shares and “investment power” includes the power to dispose or direct the disposition of shares. Common Stock beneficially owned and percentage ownership is based on 67,588,492 shares of Common Stock outstanding as of March 31, 2020.

Name and Address	Number of Shares Beneficially Owned			Percentage

Andre' DiMino		25,880,883	(1)		39	%
c/o ADM Tronics Unlimited, Inc.
224 Pegasus Avenue
Northvale, NJ 07647

The Estate of Eugene Stricker		4,188,700	(2)		6	%
c/o Fifth Avenue Venture Capital Partners
42 Barrett Road
Lawrence, NY 11559






All Executive Officers and Directors as a group		25,880,883	(3)		39	%

(1) Includes 18,691,223 shares of the Company’s common stock directly owned by Andre’ DiMino; 960 shares owned by Jenny DiMino, the spouse of Andre’ DiMino; 4,188,700 and 3,000,000 shares of the Company’s common stock held by the estate of Eugene Stricker, of which Andre’ DiMino may be deemed to be a beneficial owner by reason of his power to vote such shares pursuant to an agreement.

(2) Andre’ DiMino may be deemed to be a beneficial owner of such shares by reason of his power to vote such shares pursuant to an agreement. Reference is also made to Footnote No. 1.

(3) Reference is made to Footnote Nos. 1 and 2.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Voting Agreement

Andre' DiMino has a voting agreement with respect to 3,000,000 shares of the Company's common stock held by the estate of Eugene Stricker.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

AUDIT FEES

The aggregate fees billed for professional services rendered by Raich Ende Malter & Co. LLP ("Raich") for the audit of the Company's annual consolidated financial statements for the fiscal years ended March 31, 2020 and 2019, and for the reviews of the financial statements included in the Company's Quarterly Reports on Form 10-Q for the fiscal years ended March 31, 2020 and 2019, were approximately $104,000 for each year.

AUDIT-RELATED FEES

The aggregate fees billed in each of the fiscal years ended March 31, 2020 and 2019 for assurance and related services by Raich that are reasonably related to the performance of the audit or review of the Company's financial statements and not reported above under “Audit Fees” were $0 for each year.

TAX FEES

The aggregate fees billed in each of the fiscal years ended March 31, 2020 and 2019 for professional services rendered by Raich for tax compliance were approximately $10,000 for each year.

ALL OTHER FEES

The aggregate fees billed in each of the fiscal years ended March 31, 2020 and March 31, 2019 for products and services provided by Raich other than the services reported above under “Audit Fees”, “Audit Related Fees” and “Tax Fees” were $0.

AUDIT COMMITTEE ADMINISTRATION OF THE ENGAGEMENT

The Company does not have an audit committee.

PART III, ITEM 15. EXHIBITS

Exhibit
No.	Description

3.1	Certificate of Incorporation and amendments thereto filed on August 9, 1976 and May 15, 1978 is incorporated by reference to Exhibit 3(a) to the Company's Registration Statement Form 10 (File No. 0-17629) (the "Form 10").
3.2	Certificate of Amendment to Certificate of Incorporation filed December 9, 1996 is incorporated by reference to Exhibit 3(a) to the Company's Annual Report on Form 10-KSB for the fiscal year ended March 31, 1997.
3.3	By-Laws are incorporated by reference to Exhibit 3(b) to the Form 10.
10.1	Memorandum of Lease by and between the Company and Cresskill Industrial Park III dated as of August 26, 1993 is hereby incorporated by reference to Exhibit 10(a) to the Company's Annual Report on Form 10-KSB for the fiscal year March 31, 1994.
10.5	Agreement of January 17, 2003 by and between the Company and Fifth Avenue Venture Capital Partners is hereby incorporated by reference to Exhibit 10.5 to the Company's Annual Report on Form 10-KSB for the fiscal year ended March 31, 2003.
10.6	Amended and Restated Manufacturing Agreement, dated February 10, 2005, among the Company, Ivivi Technologies, Inc. and Sonotron Medical Systems, Inc. is incorporated by reference to the Company's Annual Report on Form 10-KSB for the fiscal year ended March 31, 2005.
10.7	Management Services Agreement, dated August 15, 2001, among the Company, Ivivi Technologies, Inc., Sonotron Medical Systems, Inc. and Pegasus Laboratories, Inc., as amended is incorporated by reference to the Company's Annual Report on Form 10-KSB form the fiscal year ended March 31, 2005.
10.8*	Master Services Agreement dated February 12, 2010 by and between ADM Tronics Unlimited Inc. and Ivivi Health Sciences LLC.

* Filed as an exhibit to the Company's annual report on Form 10K, as filed with the SEC on June 29, 2010, and incorporated herein by this reference.

14.1	Code of Ethics is incorporated by reference to the Company's Annual Report on Form 10-KSB for the fiscal year ended March 31, 2005.
21.1	Subsidiaries of the Company.
31.1	Certification of the Chief Executive Officer and Chief Financial Officer of the Company pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of the Chief Executive Officer and Chief Financial Officer of the Company pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**	XBRL Instance
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation
101.DEF**	XBRL Taxonomy Extension Definition
101.LAB**	XBRL Taxonomy Extension Labels
101.PRE**	XBRL Taxonomy Extension Presentation

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this 14th day of July, 2020.

		ADM TRONICS UNLIMITED, INC.

	By:	/s/ Andre' DiMino
		Andre' Di Mino
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

		Title	Date

/s/	Andre' DiMino	Chief Executive Officer (Principal	July 14, 2020
	Andre' DiMino	Executive Officer, Principal
		Financial Officer and Principal
		Accounting Officer) and Director

EX-21.1 2 ex_193822.htm EXHIBIT 21.1 ex_193822.htm

EXHIBIT 21.1

Subsidiary of the Registrant

Name	Jurisdiction of Incorporation
Sonotron Medical Systems, Inc.	Delaware

EX-31.1 3 ex_193590.htm EXHIBIT 31.1 ex_193590.htm

EXHIBIT 31.1

CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES - OXLEY ACT OF 2002 AND

SECURITIES AND EXCHANGE COMMISSION RELEASE 34-46427

I, Andre' DiMino, certify that:

1. I have reviewed this quarterly report on Form 10-K of ADM Tronics Unlimited, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am the registrant's only certifying officer and am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 14, 2020		/s/ Andre' DiMino
		Andre' DiMino
		Chief Executive Officer and Chief Financial Officer

A signed original of this written statement required by Section 302 has been provided to ADM Tronics Unlimited, Inc. and will be retained by ADM Tronics Unlimited, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.1 4 ex_193591.htm EXHIBIT 32.1 ex_193591.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual Report of ADM Tronics Unlimited, Inc. (the "Company") on Form 10-K for the twelve months ended March 31, 2020, (the "Report"), filed with the Securities and Exchange Commission, Andre' DiMino, Chief Executive Officer and Chief Financial Officer, of the Company hereby certifies pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of the dates presented and the result of operations of the Company for the periods presented.

Date: July 14, 2020		/s/ Andre' DiMino
		Chief Executive Officer and
		Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ADM Tronics Unlimited, Inc. and will be retained by ADM Tronics Unlimited, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 admt-20200331.xml XBRL INSTANCE DOCUMENT 1 2 3 2 -101875 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font: inherit;">8</div> – LEASES    </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2028. </div>The Company The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020:</div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 81%; border-bottom: thin solid rgb(0, 0, 0);">For the Years Ending March 31,</td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">105,625</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">106,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">347,344</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">865,469</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Less:</div> Amount attributable to imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(159,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net liability at March 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">706,307</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Weighted average remaining lease term (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8.3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Weighted average discount rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Rent and real estate tax expense for all facilities for the years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> was approximately <div style="display: inline; font-style: italic; font: inherit;">$135,000</div> and <div style="display: inline; font-style: italic; font: inherit;">$132,000,</div> respectively, and are reported as a component of cost of sales and selling, general and administrative expenses in the accompanying statement of operations. The Company paid in <div style="display: inline; font-style: italic; font: inherit;">$101,875</div> in lease payments during the year.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">During <div style="display: inline; font-style: italic; font: inherit;"> September 2016 </div>the Company leased equipment with a cost of approximately <div style="display: inline; font-style: italic; font: inherit;">$129,000,</div> under provisions of various long-term financing leases whereby the minimum lease payments have been capitalized. Accumulated depreciation at <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>is approximately <div style="display: inline; font-style: italic; font: inherit;">$88,000.</div> The leases expire over various years through <div style="display: inline; font-style: italic; font: inherit;">2021.</div> Depreciation of the leased assets is included in depreciation and amortization expense. The lease obligations are secured by the leased assets.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Future minimum lease payments under the above financing leases, as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>are approximately as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 85%; border-bottom: thin solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">For the Years Ending March 31,</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 27pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">23,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic;">Less:</div> Amount attributable to imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Present value of minimum lease payments</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">21,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-style: italic;">Less:</div> Current maturities</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">21,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> </table> </div></div> 64792 771098 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: auto; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Long Term</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 55%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Raw materials</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">289,369</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">121,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">410,382</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished goods</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">83,266</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">11,067</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">94,333</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Totals</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">372,635</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">132,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">504,715</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: auto; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Current</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Long Term</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Raw materials</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">273,039</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">84,721</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">357,760</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished goods</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,269</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">736</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">54,005</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Totals</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">326,308</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">85,457</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">411,765</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 81%; border-bottom: thin solid rgb(0, 0, 0);">For the years ending March 31,</td> <td> </td> <td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">Amount</td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 99pt;">2021</td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">11,735</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="padding-left: 99pt;">2022</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">11,735</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 99pt;">2023</td> <td style="width: 1%; padding-bottom: 1px;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">11,736</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">35,206</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> </table></div> 3153 3754 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">SHIPPING AND HANDLING COSTS </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shipping and handling costs incurred for the years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> were approximately <div style="display: inline; font-style: italic; font: inherit;">$3,153</div> and <div style="display: inline; font-style: italic; font: inherit;">$3,754,</div> respectively. Such costs are included in selling, general, and administrative expenses in the accompanying consolidated statements of operations.</div></div></div></div></div></div></div> 11735 11736 11735 P90D P5Y false --03-31 FY 2020 2020-03-31 10-K 0000849401 67588492 Yes false Non-accelerated Filer Yes 11490044 ADM TRONICS UNLIMITED, INC. false true No No COMMON STOCK, $.0005 PAR VALUE

365475

275591

860539

916844

330090

136188

150549

145602

108099

P10Y

P15Y

33294069

41353

59877

225000

160000

225000

160000

2056

505389

1970705

1061149

5053089

1985501

1099983

1459608

4545092

2695413

2827421

2357676

1717671

88000

1555687

1693532

1438714

-116973

-137845

1293000

0.0005

150000000

67588492

33794

0.48

0.58

0.83

0.88

0.09

0.12

354745

321441

216000

1911972

1454700

-18478

-1000

0.0537

1019000

1107000

88000

15000

1019000

1107000

536000

637000

54000

41000

429000

37503

37659

22682

22108

39559

39055

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font: inherit;">13</div> – STOCK BASED COMPENSATION</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font: inherit;"> September 2, 2015, </div>ADM granted <div style="display: inline; font-style: italic; font: inherit;">3,000,000</div> stock options to employees at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.20</div> per option and with a term of <div style="display: inline; font-style: italic; font: inherit;">three</div> years. The options were valued at <div style="display: inline; font-style: italic; font: inherit;">$598,699</div> using the Black Scholes option pricing model with the following assumptions: risk free interest rate of <div style="display: inline; font-style: italic; font: inherit;">2.03%,</div> volatility of <div style="display: inline; font-style: italic; font: inherit;">353%,</div> estimated useful life of <div style="display: inline; font-style: italic; font: inherit;">3</div> years and dividend rate of <div style="display: inline; font-style: italic; font: inherit;">0%.</div> The options expired during the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font: inherit;"> January 13, 2020, </div>ADM granted <div style="display: inline; font-style: italic; font: inherit;">300,000</div> stock options to <div style="display: inline; font-style: italic; font: inherit;">one</div> employee at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.20</div> per option with a term of <div style="display: inline; font-style: italic; font: inherit;">two</div> years subject to vesting in <div style="display: inline; font-style: italic; font: inherit;">four</div> equal amounts of <div style="display: inline; font-style: italic; font: inherit;">75,000</div> share every <div style="display: inline; font-style: italic; font: inherit;">six</div> months. The options were valued at <div style="display: inline; font-style: italic; font: inherit;">$35,206</div> using the Black Scholes option pricing model with the following assumptions: risk free interest rate of <div style="display: inline; font-style: italic; font: inherit;">1.58%,</div> volatility of <div style="display: inline; font-style: italic; font: inherit;">132%,</div> estimated useful life of <div style="display: inline; font-style: italic; font: inherit;">3</div> years and dividend rate of <div style="display: inline; font-style: italic; font: inherit;">0%.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The following table summarizes information on all common share purchase options issued by us as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2020</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"># of Shares</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Weighted</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"># of Shares</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Weighted</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Average</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Average</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Exercise</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Exercise</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Price</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Price</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, beginning of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,000,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">300,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(3,000,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, end of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">300,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable, end of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>there was <div style="display: inline; font-style: italic; font: inherit;">$35,206</div> of unrecognized compensation costs, which is expected to be recognized as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 81%; border-bottom: thin solid rgb(0, 0, 0);">For the years ending March 31,</td> <td> </td> <td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">Amount</td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 99pt;">2021</td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">11,735</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="padding-left: 99pt;">2022</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">11,735</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="padding-left: 99pt;">2023</td> <td style="width: 1%; padding-bottom: 1px;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">11,736</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 16%; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">35,206</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div></div>

330090

100017

139322

-0.01

-2

0.04

0.21

-2.28

-0.17

0.07

35206

0.232

75000

21000

21458

31196

22450

23000

2000

129000

P10Y

P15Y

14093

12035

14091

12035

7710

2882

2465

2882

35794

20934

21703

8899

P6Y

1574020

1564254

-26237

-356579

69522

14000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">INCOME TAXES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We report the results of our operations as part of a consolidated Federal tax return with our subsidiary. Deferred income taxes result primarily from temporary differences between financial and tax reporting. Deferred tax assets and liabilities are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates. A valuation allowance is recorded to reduce a deferred tax asset to that portion that is expected to more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> be realized.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company has adopted the authoritative accounting guidance with respect to accounting for uncertainty in income taxes, which clarified the accounting and disclosures for uncertain tax positions related to income taxes recognized in the consolidated financial statements and addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> sustain the position following an audit. For tax positions meeting the more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than <div style="display: inline; font-style: italic; font: inherit;">50</div> percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, </div>as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Jurisdiction</div></div> </td> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;">Fiscal Year</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Federal</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2015 and beyond</div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New Jersey</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2014 and beyond</div></div> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">There are currently <div style="display: inline; font-style: italic; font: inherit;">no</div> tax years under examination by any major tax jurisdictions.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the Company has <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">no</div></div> accrued interest or penalties related to uncertain tax positions.</div></div></div></div></div></div></div>

89884

-11373

8695

74441

-14361

1167

33304

199274

-88000

15000

-39305

8771

229415

230780

-5283

15726

8424

8807

8424

8807

83266

11067

94333

53269

736

54005

372635

132080

504715

326308

85457

411765

372635

326308

132080

85457

289369

121013

410382

273039

84721

357760

136465

131089

25576

26948

3750

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 20%; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="width: 81%; border-bottom: thin solid rgb(0, 0, 0);">For the Years Ending March 31,</td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: thin solid rgb(0, 0, 0);"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">101,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">105,625</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">106,875</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">347,344</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">865,469</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Less:</div> Amount attributable to imputed interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(159,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net liability at March 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">706,307</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Weighted average remaining lease term (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8.3</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: left;">Weighted average discount rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">%</td> </tr> </table></div>

967344

865469

347344

101875

106875

105625

101875

159161

1714190

1110434

5053089

4545092

1007883

1087984

706307

22450

2021-05-15

400000

30000

169885

7500

199810

-172073

137698

-14860

69960

-275543

-95759

-342579

-95759

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">RECENT ACCOUNTING PRONOUNCEMENTS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Lease Accounting</div>. In <div style="display: inline; font-style: italic; font: inherit;"> February 2016, </div>the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changes financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of <div style="display: inline; font-style: italic; font: inherit;"> April 1, 2019, </div>using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (<div style="display: inline; font-style: italic; font: inherit;">1</div>) whether any expired or existing contracts are or contain leases, (<div style="display: inline; font-style: italic; font: inherit;">2</div>) the lease classification for any expired or existing leases, and (<div style="display: inline; font-style: italic; font: inherit;">3</div>) the initial direct costs for any existing leases.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of <div style="display: inline; font-style: italic; font: inherit;">twelve</div> months or less and does <div style="display: inline; font-style: italic; font: inherit;">not</div> contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning <div style="display: inline; font-style: italic; font: inherit;"> April 1, 2019 </div>when the Company recognized (a) a lease liability of <div style="display: inline; font-style: italic; font: inherit;">$771,098,</div> which represents the present value of the remaining lease payments of <div style="display: inline; font-style: italic; font: inherit;">$967,344,</div> discounted using the Company's incremental borrowing rate of <div style="display: inline; font-style: italic; font: inherit;">5%</div> and (b) the related right-of-use asset of <div style="display: inline; font-style: italic; font: inherit;">$771,098</div> which represents the lease liability. Prior periods were <div style="display: inline; font-style: italic; font: inherit;">not</div> restated. Adoption of this standard had <div style="display: inline; font-style: italic; font: inherit;">no</div> change on financing leases previously subject to capital lease treatment under ASC Topic <div style="display: inline; font-style: italic; font: inherit;">840,</div> Leases. See Note <div style="display: inline; font-style: italic; font: inherit;">8</div> for further discussion of leases. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>the FASB issued ASU-<div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13</div> “Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are <div style="display: inline; font-style: italic; font: inherit;">not</div> accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2019. </div>The Company is evaluating the potential impact on the Company’s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Management does <div style="display: inline; font-style: italic; font: inherit;">not</div> believe that any other recently issued, but <div style="display: inline; font-style: italic; font: inherit;">not</div> yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements. </div></div></div></div></div></div></div>

17152

18141

2015 2016 2017 2018 2019 2020

2014 2015 2016 2017 2018 2019 2020

1617409

1938974

-43389

-374720

58477

-147023

45157

-81849

-403099

110228

135000

132000

771098

706307

101875

771098

706307

0.05

P8Y109D

2468000

90538

90764

37083

14860

0.01

5000000

23525

28582

381000

170000

386000

2000

203560

57958

95461

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: auto; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2020</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Machinery and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">199,810</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">199,810</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">3,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">3,750</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">203,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">203,560</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accumulated depreciation and amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(145,602</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(108,099</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Property and equipment, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">57,958</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">95,461</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div>

P5Y

P7Y

65000

35000

330090

309885

216115

32188

32187

589373

673855

-29988964

-29893205

324596

364418

3485992

3018954

1368365

1400918

716709

1318814

730634

969506

1043769

954396

1400918

730634

716709

969506

3161396

2654536

324596

364418

324596

364418

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">REVENUE RECOGNITION</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ELECTRONICS:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited <div style="display: inline; font-style: italic; font: inherit;">90</div>-day warranty on our electronics products and contract manufacturing and a limited <div style="display: inline; font-style: italic; font: inherit;">5</div>-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have <div style="display: inline; font-style: italic; font: inherit;">no</div> other post shipment obligations. Based on prior experience, <div style="display: inline; font-style: italic; font: inherit;">no</div> amounts have been accrued for potential warranty costs and actual costs were less than <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">$2,000</div>,</div> for each of the fiscal years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> For contract manufacturing, revenues are recognized after shipment of the completed products.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately <div style="display: inline; font-style: italic; font: inherit;">$216,000</div> as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019 </div>were recognized as revenues during the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">CHEMICAL PRODUCTS:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when <div style="display: inline; font-style: italic; font: inherit;">no</div> right of return exists.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ENGINEERING SERVICES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services on a monthly basis over time as the applicable performance obligations are satisfied.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">All revenue is recognized net of discounts.</div></div></div></div></div></div></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Chemical</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Electronics</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Engineering</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Year ended March 31, 2020</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Revenue from external customers</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,368,365</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,400,918</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">716,709</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,485,992</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Segment operating income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">58,477</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(147,023</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">45,157</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(43,389</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Year ended March 31, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Revenue from external customers</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,318,814</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">730,634</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">969,506</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,018,954</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Segment operating income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(81,849</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(403,099</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">110,228</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(374,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total assets at March 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,053,89</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,970,705</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,061,149</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,053,089</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total assets at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,985,501</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,099,983</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,459,608</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">4,545,092</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2020</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"># of Shares</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Weighted</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"># of Shares</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Weighted</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Average</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Average</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Exercise</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Exercise</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Price</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Price</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, beginning of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,000,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">300,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(3,000,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, end of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">300,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">0.20</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px; border-bottom: thin solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable, end of year</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font: inherit;">10</div> - SEGMENT INFORMATION</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Information about segments is as follows: </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Chemical</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Electronics</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Engineering</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Year ended March 31, 2020</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Revenue from external customers</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,368,365</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,400,918</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">716,709</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,485,992</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Segment operating income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">58,477</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(147,023</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">45,157</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(43,389</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Year ended March 31, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 8%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Revenue from external customers</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,318,814</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">730,634</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">969,506</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3,018,954</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 56%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Segment operating income (loss)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(81,849</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(403,099</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">110,228</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">(374,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total assets at March 31, 2020</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,053,89</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,970,705</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,061,149</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,053,089</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 8%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 56%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total assets at March 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,985,501</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,099,983</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,459,608</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 8%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">4,545,092</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div></div>

1005354

1243011

3.53

1.32

0.0203

0.0158

3000000

300000

75000

300000

3000000

300000

0.20

P3Y

P2Y

P3Y

598699

35206

67588492

30000

169885

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font: inherit;">2</div> - SIGNIFICANT ACCOUNTING POLICIES</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">PRINCIPLES OF CONSOLIDATION</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its wholly owned subsidiary Sonotron (the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">USE OF ESTIMATES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and, accordingly, require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our deferred tax assets and related valuation allowance, write down of inventory, impairment of long-lived assets, allowance for doubtful accounts, and warranty reserves. Actual amounts could differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">FAIR VALUE OF FINANCIAL INSTRUMENTS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">CASH AND CASH EQUIVALENTS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Cash equivalents are comprised of certain highly liquid investments with original maturities of <div style="display: inline; font-style: italic; font: inherit;">three</div> months or less when purchased. We maintain our cash in bank deposit accounts, which at times, <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed federally insured limits. We have <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses to date as a result of this policy. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of <div style="display: inline; font-style: italic; font: inherit;">$250,000</div> per institution. At <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>approximately <div style="display: inline; font-style: italic; font: inherit;">$1,293,000</div> exceeded the FDIC limit. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">  </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accounts receivable are stated at the amount management expects to collect from outstanding balances. The carrying amounts of accounts receivable is reduced by a valuation allowance that reflects management's best estimate of the amounts that will <div style="display: inline; font-style: italic; font: inherit;">not</div> be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will <div style="display: inline; font-style: italic; font: inherit;">not</div> be collected. Management provides for probable uncollectible amounts through a charge to expenses and a credit to a valuation allowance, based on its assessment of the current status of individual accounts. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable. Allowance for doubtful accounts was increased for the fiscal year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>to <div style="display: inline; font-style: italic; font: inherit;">$225,000,</div> compared to <div style="display: inline; font-style: italic; font: inherit;">$160,000</div> at <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"></div> <div >   </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">REVENUE RECOGNITION</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ELECTRONICS:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited <div style="display: inline; font-style: italic; font: inherit;">90</div>-day warranty on our electronics products and contract manufacturing and a limited <div style="display: inline; font-style: italic; font: inherit;">5</div>-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have <div style="display: inline; font-style: italic; font: inherit;">no</div> other post shipment obligations. Based on prior experience, <div style="display: inline; font-style: italic; font: inherit;">no</div> amounts have been accrued for potential warranty costs and actual costs were less than <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">$2,000</div>,</div> for each of the fiscal years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> For contract manufacturing, revenues are recognized after shipment of the completed products.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately <div style="display: inline; font-style: italic; font: inherit;">$216,000</div> as of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019 </div>were recognized as revenues during the year ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">CHEMICAL PRODUCTS:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when <div style="display: inline; font-style: italic; font: inherit;">no</div> right of return exists.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ENGINEERING SERVICES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We provide certain engineering services, including research, development, quality control and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services on a monthly basis over time as the applicable performance obligations are satisfied.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">All revenue is recognized net of discounts.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">WARRANTY LIABILITIES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that <div style="display: inline; font-style: italic; font: inherit;">no</div> warranty liability is required as of the consolidated balance sheet dates. However, the Company periodically reviews the adequacy of its product warranties and will record an accrued warranty reserve if necessary.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">INVENTORIES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inventories are stated at the lower of cost (<div style="display: inline; font-style: italic; font: inherit;">first</div>-in, <div style="display: inline; font-style: italic; font: inherit;">first</div>-out method) and net realizable value. Inventories that are expected to be sold within <div style="display: inline; font-style: italic; font: inherit;">one</div> operating cycle (<div style="display: inline; font-style: italic; font: inherit;">1</div> year) are classified as a current asset. Inventories that are <div style="display: inline; font-style: italic; font: inherit;">not</div> expected to be sold within <div style="display: inline; font-style: italic; font: inherit;">1</div> year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off annually based on prior and expected future usage.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">PROPERTY AND EQUIPMENT</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over <div style="display: inline; font-style: italic; font: inherit;">five</div> to <div style="display: inline; font-style: italic; font: inherit;">seven</div> years, the estimated useful lives of the property and equipment.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">INTANGIBLE ASSETS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount <div style="display: inline; font-style: italic; font: inherit;"> may </div><div style="display: inline; font-style: italic; font: inherit;">not</div> be recoverable. In reviewing for impairment, the Company compares the carrying value of the relevant asset to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and its carrying value. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">ADVERTISING COSTS </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Advertising costs are expensed as incurred and amounted to <div style="display: inline; font-style: italic; font: inherit;">$41,353</div> and <div style="display: inline; font-style: italic; font: inherit;">$59,877</div> for the fiscal years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">  </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">SHIPPING AND HANDLING COSTS </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Shipping and handling costs incurred for the years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019</div> were approximately <div style="display: inline; font-style: italic; font: inherit;">$3,153</div> and <div style="display: inline; font-style: italic; font: inherit;">$3,754,</div> respectively. Such costs are included in selling, general, and administrative expenses in the accompanying consolidated statements of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">INCOME TAXES</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We report the results of our operations as part of a consolidated Federal tax return with our subsidiary. Deferred income taxes result primarily from temporary differences between financial and tax reporting. Deferred tax assets and liabilities are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates. A valuation allowance is recorded to reduce a deferred tax asset to that portion that is expected to more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> be realized.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company has adopted the authoritative accounting guidance with respect to accounting for uncertainty in income taxes, which clarified the accounting and disclosures for uncertain tax positions related to income taxes recognized in the consolidated financial statements and addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than <div style="display: inline; font-style: italic; font: inherit;">not</div> sustain the position following an audit. For tax positions meeting the more-likely-than-<div style="display: inline; font-style: italic; font: inherit;">not</div> threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than <div style="display: inline; font-style: italic; font: inherit;">50</div> percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, </div>as follows:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Jurisdiction</div></div> </td> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;">Fiscal Year</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Federal</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2015 and beyond</div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New Jersey</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2014 and beyond</div></div> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">There are currently <div style="display: inline; font-style: italic; font: inherit;">no</div> tax years under examination by any major tax jurisdictions.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the Company has <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">no</div></div> accrued interest or penalties related to uncertain tax positions.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">NET EARNINGS PER SHARE</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">We compute basic earnings per share by dividing net income/loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. Common equivalent shares are excluded from the computation of net earnings per share if their effect is anti-dilutive.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Per share basic and diluted (loss) amounted to (<div style="display: inline; font-style: italic; font: inherit;">$0.00</div>) and $(<div style="display: inline; font-style: italic; font: inherit;">0.01</div>) for the fiscal years ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> respectively.  </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">RECLASSIFICATION</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certain items in the prior financial statements have been reclassified to conform to the current year presentation.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">RECENT ACCOUNTING PRONOUNCEMENTS</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Lease Accounting</div>. In <div style="display: inline; font-style: italic; font: inherit;"> February 2016, </div>the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changes financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of <div style="display: inline; font-style: italic; font: inherit;"> April 1, 2019, </div>using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (<div style="display: inline; font-style: italic; font: inherit;">1</div>) whether any expired or existing contracts are or contain leases, (<div style="display: inline; font-style: italic; font: inherit;">2</div>) the lease classification for any expired or existing leases, and (<div style="display: inline; font-style: italic; font: inherit;">3</div>) the initial direct costs for any existing leases.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of <div style="display: inline; font-style: italic; font: inherit;">twelve</div> months or less and does <div style="display: inline; font-style: italic; font: inherit;">not</div> contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning <div style="display: inline; font-style: italic; font: inherit;"> April 1, 2019 </div>when the Company recognized (a) a lease liability of <div style="display: inline; font-style: italic; font: inherit;">$771,098,</div> which represents the present value of the remaining lease payments of <div style="display: inline; font-style: italic; font: inherit;">$967,344,</div> discounted using the Company's incremental borrowing rate of <div style="display: inline; font-style: italic; font: inherit;">5%</div> and (b) the related right-of-use asset of <div style="display: inline; font-style: italic; font: inherit;">$771,098</div> which represents the lease liability. Prior periods were <div style="display: inline; font-style: italic; font: inherit;">not</div> restated. Adoption of this standard had <div style="display: inline; font-style: italic; font: inherit;">no</div> change on financing leases previously subject to capital lease treatment under ASC Topic <div style="display: inline; font-style: italic; font: inherit;">840,</div> Leases. See Note <div style="display: inline; font-style: italic; font: inherit;">8</div> for further discussion of leases. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>the FASB issued ASU-<div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13</div> “Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are <div style="display: inline; font-style: italic; font: inherit;">not</div> accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2019. </div>The Company is evaluating the potential impact on the Company’s consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Management does <div style="display: inline; font-style: italic; font: inherit;">not</div> believe that any other recently issued, but <div style="display: inline; font-style: italic; font: inherit;">not</div> yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements. </div></div>

33794

33294069

-29550626

3777237

33794

33294069

-29893205

3434658

33794

33294069

-29988964

3338899

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-; min-width: 700px;"> <tr> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Jurisdiction</div></div> </td> <td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-weight: bold;">Fiscal Year</div></div> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Federal</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2015 and beyond</div></div> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="vertical-align:middle;width:46%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New Jersey</div> </td> <td style="vertical-align:middle;width:54%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;"><div style="display: inline; font-style: italic; font: inherit;">2014 and beyond</div></div> </td> </tr> </table></div>

67588492

xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000849401 2015-09-02 2015-09-02 0000849401 admt:EngineeringServicesMember admt:QolMember 2017-04-01 2018-03-31 0000849401 2018-04-01 2019-03-31 0000849401 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember admt:TwoCustomersMember 2018-04-01 2019-03-31 0000849401 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember admt:ForeignCustomersMember 2018-04-01 2019-03-31 0000849401 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember admt:TwoCustomersMember 2018-04-01 2019-03-31 0000849401 admt:PatentsAndTrademarksMember 2018-04-01 2019-03-31 0000849401 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2019-03-31 0000849401 srt:MaximumMember 2018-04-01 2019-03-31 0000849401 admt:ChemicalMember 2018-04-01 2019-03-31 0000849401 admt:ChemicalMember us-gaap:NonUsMember 2018-04-01 2019-03-31 0000849401 admt:ChemicalMember country:US 2018-04-01 2019-03-31 0000849401 admt:ElectronicsMember 2018-04-01 2019-03-31 0000849401 admt:ElectronicsMember us-gaap:NonUsMember 2018-04-01 2019-03-31 0000849401 admt:ElectronicsMember country:US 2018-04-01 2019-03-31 0000849401 admt:EngineeringMember 2018-04-01 2019-03-31 0000849401 admt:EngineeringMember us-gaap:NonUsMember 2018-04-01 2019-03-31 0000849401 admt:EngineeringMember country:US 2018-04-01 2019-03-31 0000849401 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2019-03-31 0000849401 us-gaap:CommonStockMember 2018-04-01 2019-03-31 0000849401 us-gaap:RetainedEarningsMember 2018-04-01 2019-03-31 0000849401 us-gaap:NonUsMember 2018-04-01 2019-03-31 0000849401 country:US 2018-04-01 2019-03-31 0000849401 2019-04-01 2020-03-31 0000849401 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember admt:ThreeCustomersMember 2019-04-01 2020-03-31 0000849401 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember admt:ForeignCustomersMember 2019-04-01 2020-03-31 0000849401 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember admt:OneCustomerMember 2019-04-01 2020-03-31 0000849401 us-gaap:RevolvingCreditFacilityMember 2019-04-01 2020-03-31 0000849401 admt:PatentsAndTrademarksMember srt:MaximumMember 2019-04-01 2020-03-31 0000849401 admt:PatentsAndTrademarksMember srt:MinimumMember 2019-04-01 2020-03-31 0000849401 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-04-01 2020-03-31 0000849401 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2019-04-01 2020-03-31 0000849401 us-gaap:StateAndLocalJurisdictionMember us-gaap:NewJerseyDivisionOfTaxationMember 2019-04-01 2020-03-31 0000849401 admt:ElectronicControllersForSpasAndHotTubsMember 2019-04-01 2020-03-31 0000849401 admt:ElectronicProductsMember 2019-04-01 2020-03-31 0000849401 srt:MaximumMember 2019-04-01 2020-03-31 0000849401 srt:MinimumMember 2019-04-01 2020-03-31 0000849401 admt:ChemicalMember 2019-04-01 2020-03-31 0000849401 admt:ChemicalMember us-gaap:NonUsMember 2019-04-01 2020-03-31 0000849401 admt:ChemicalMember country:US 2019-04-01 2020-03-31 0000849401 admt:ElectronicsMember 2019-04-01 2020-03-31 0000849401 admt:ElectronicsMember us-gaap:NonUsMember 2019-04-01 2020-03-31 0000849401 admt:ElectronicsMember country:US 2019-04-01 2020-03-31 0000849401 admt:EngineeringMember 2019-04-01 2020-03-31 0000849401 admt:EngineeringMember us-gaap:NonUsMember 2019-04-01 2020-03-31 0000849401 admt:EngineeringMember country:US 2019-04-01 2020-03-31 0000849401 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2020-03-31 0000849401 us-gaap:CommonStockMember 2019-04-01 2020-03-31 0000849401 us-gaap:RetainedEarningsMember 2019-04-01 2020-03-31 0000849401 us-gaap:NonUsMember 2019-04-01 2020-03-31 0000849401 country:US 2019-04-01 2020-03-31 0000849401 2020-01-13 2020-01-13 0000849401 admt:VestingInFourEqualAmountEverySixMonthsMember 2020-01-13 2020-01-13 0000849401 admt:LoansFromSBAPPPMember us-gaap:SubsequentEventMember 2020-05-01 2020-05-31 0000849401 admt:CivilSuitAgainstAccountingFirmMember us-gaap:SubsequentEventMember 2020-06-02 2020-06-02 0000849401 2016-09-30 0000849401 2018-03-31 0000849401 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000849401 us-gaap:CommonStockMember 2018-03-31 0000849401 us-gaap:RetainedEarningsMember 2018-03-31 0000849401 us-gaap:RevolvingCreditFacilityMember 2018-06-15 0000849401 2018-09-30 0000849401 2019-03-31 0000849401 us-gaap:RevolvingCreditFacilityMember 2019-03-31 0000849401 admt:PatentsAndTrademarksMember 2019-03-31 0000849401 admt:CurrentMember 2019-03-31 0000849401 admt:LongTermMember 2019-03-31 0000849401 admt:ChemicalMember 2019-03-31 0000849401 admt:ElectronicsMember 2019-03-31 0000849401 admt:EngineeringMember 2019-03-31 0000849401 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000849401 us-gaap:CommonStockMember 2019-03-31 0000849401 us-gaap:RetainedEarningsMember 2019-03-31 0000849401 us-gaap:AccountingStandardsUpdate201602Member 2019-04-01 0000849401 2020-03-31 0000849401 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000849401 admt:PatentsAndTrademarksMember 2020-03-31 0000849401 admt:CurrentMember 2020-03-31 0000849401 admt:LongTermMember 2020-03-31 0000849401 admt:QolMember 2020-03-31 0000849401 admt:QolMember 2020-03-31 0000849401 admt:ChemicalMember 2020-03-31 0000849401 admt:ElectronicsMember 2020-03-31 0000849401 admt:EngineeringMember 2020-03-31 0000849401 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000849401 us-gaap:CommonStockMember 2020-03-31 0000849401 us-gaap:RetainedEarningsMember 2020-03-31 0000849401 2020-07-14

EX-101.SCH 6 admt-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Stockholder's Equity (Deficiency) (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Nature of Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Inventories link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Intangible Assets link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Line of Credit link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Leases link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Concentrations link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Segment Information link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Stock Based Compensation link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Legal Proceedings link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 15 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 2 - Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 3 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 4 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 5 - Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 8 - Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 10 - Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 12 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 13 - Stock Based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 2 - Significant Accounting Policies - Income Tax Returns Jurisdictions Subject to Examination (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 3 - Inventories - Summary of Inventory (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 4 - Property and Equipment - Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 5 - Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 5 - Intangible Assets - Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 5 - Intangible Assets - Estimated Aggregate Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 7 - Line of Credit (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 8 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 8 - Leases - Future Minimum Lease Payments for Operating Lease (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 8 - Leases - Future Minimum Lease Payments for Financing Leases (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 9 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 10 - Segment Information - Summary of Segment Information (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information - Net Revenue, Classified by Geography (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 12 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 12 - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 12 - Income Taxes - Provision for Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 13 - Stock Based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 13 - Stock Based Compensation - Summary of Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 13 - Stock Based Compensation - Unrecognized Compensation Costs (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 14 - Legal Proceedings (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 15 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 admt-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 admt-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 admt-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo 2022 Other income (expense): Fair Value of Financial Instruments, Policy [Policy Text Block] Note To Financial Statement Details Textual us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree 2023 Significant Accounting Policies us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour 2024 2021 us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Note 2 - Significant Accounting Policies us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive 2025 2022 us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Note 3 - Inventories Note 4 - Property and Equipment Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Note 5 - Intangible Assets Note 8 - Leases us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths 2021 Note 10 - Segment Information Long-term liabilities Note 11 - Disaggregated Net Revenues and Segment Information Note 12 - Income Taxes Income Tax Disclosure [Text Block] Note 13 - Stock Based Compensation Note 2 - Significant Accounting Policies - Income Tax Returns Jurisdictions Subject to Examination (Details) Note 3 - Inventories - Summary of Inventory (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Lessee, Operating Lease, Liability, Maturity [Table Text Block] Note 4 - Property and Equipment - Property and Equipment (Details) Other assets us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 Finite-Lived Intangible Assets, Remaining Amortization Period (Year) Note 5 - Intangible Assets - Intangible Assets (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 5 - Intangible Assets - Estimated Aggregate Future Amortization Expense (Details) us-gaap_DueToRelatedPartiesCurrent Due to stockholder Note 8 - Leases - Future Minimum Lease Payments for Operating Lease (Details) us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-Lived Intangible Asset, Useful Life (Year) Note 8 - Leases - Future Minimum Lease Payments for Financing Leases (Details) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) Note 10 - Segment Information - Summary of Segment Information (Details) Earnings Per Share, Policy [Policy Text Block] Note 11 - Disaggregated Net Revenues and Segment Information - Net Revenue, Classified by Geography (Details) Note 12 - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) Note 12 - Income Taxes - Provision for Income Taxes (Details) Note 13 - Stock Based Compensation - Summary of Stock Option Activity (Details) Note 13 - Stock Based Compensation - Unrecognized Compensation Costs (Details) Weighted Average Amortization Period (Year) Notes To Financial Statements Operating expenses: Notes To Financial Statements [Abstract] Income Tax, Policy [Policy Text Block] us-gaap_LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party Share-based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] us-gaap_Depreciation Depreciation, Total us-gaap_DepreciationDepletionAndAmortization Depreciation and amortization Intangible Assets Disclosure [Text Block] Inventories - long-term portion us-gaap_AssetsCurrent Total current assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable, weighted average exercise price (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable, end of year (in shares) Line of credit Advertising Cost [Policy Text Block] Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,492 shares issued and outstanding Adjustments to reconcile net income (loss) to net cash (used in) operating activities: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Common stock, authorized (in shares) Common stock, issued (in shares) us-gaap_ContractWithCustomerLiabilityCurrent Customer deposits Expired, weighted average exercise price (in dollars per share) Common stock, par value (in dollars per share) Issued, weighted average exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) Exercised, weighted average exercise price (in dollars per share) us-gaap_AccruedLiabilitiesCurrent Accrued expenses and other current liabilities Statistical Measurement [Domain] us-gaap_OperatingLeasePayments Operating Lease, Payments Maximum [Member] Minimum [Member] Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Accounts payable Product and Service [Axis] Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding, beginning of year (in shares) Outstanding, end of year (in shares) Product and Service [Domain] us-gaap_DeferredTaxAssetsNet Deferred tax asset, net Statistical Measurement [Axis] Investment, Name [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Expired (in shares) Litigation Case [Axis] Credit Facility [Axis] Litigation Case [Domain] Credit Facility [Domain] Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding Preferred stock, issued (in shares) Intangible Assets, Finite-Lived, Policy [Policy Text Block] Interest us-gaap_PolicyTextBlockAbstract Accounting Policies Investment, Name [Axis] us-gaap_DeferredTaxAssetsOther Other Property, Plant and Equipment Disclosure [Text Block] Geographical [Axis] Property, Plant and Equipment [Table Text Block] Geographical [Domain] Preferred stock, authorized (in shares) Inventories Preferred stock, par value (in dollars per share) Net revenues Revenue from Contract with Customer, Including Assessed Tax us-gaap_PaymentsToAcquireIntangibleAssets Purchase of patents us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation Finished goods Customer [Axis] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) Customer [Domain] us-gaap_InventoryGross Totals Current liabilities: Vesting [Axis] Vesting [Domain] Raw materials Cash paid for: us-gaap_Assets Total assets Total assets us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life (Year) us-gaap_OperatingLeaseExpense Operating Lease, Expense us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Cash flows from operating activities: Schedule of Segment Reporting Information, by Segment [Table Text Block] Revenue [Policy Text Block] Statement [Line Items] Accounts receivable, allowance for doubtful accounts Engineering [Member] Represents the engineering segment of the company. Legal Matters and Contingencies [Text Block] Accounts receivable, net of allowance for doubtful accounts of $225,000 and $160,000 at March 31, 2020 and 2019, respectively Deferred tax asset Share-based Payment Arrangement [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Additional paid-in capital Stockholders' equity: Property, Plant and Equipment, Policy [Policy Text Block] us-gaap_NonoperatingIncomeExpense Total other income (expense) Segment Reporting Disclosure [Text Block] Net operating loss carry-forward Research & development tax credit carry-forward Current assets: Net (loss) Net (loss) Intangible assets, accumulated amortization Accumulated Amortization Intangible assets, net of accumulated amortization of $14,093 and $12,035 at March 31, 2020 and 2019, respectively Finite-Lived Intangible Assets, Net, Ending Balance Net Carrying Amount Inventory, Policy [Policy Text Block] Interest income Cost us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by (used in) financing activities us-gaap_Liabilities Total liabilities us-gaap_OperatingIncomeLoss Loss from operations Segment operating income (loss) us-gaap_ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by (used in) operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash (used in) investing activities Prepaid expenses and other current assets Inventory [Axis] us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net (decrease) in cash and cash equivalents Inventory [Domain] us-gaap_GrossProfit Gross Profit Cost of sales Write-off of inventories Property and equipment, accumulated depreciation Accumulated depreciation and amortization Property and equipment, net of accumulated depreciation of $145,602 and $108,099 at March 31, 2020 and 2019, respectively Property and equipment, net Accounting Standards Update 2016-02 [Member] us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total us-gaap_PropertyPlantAndEquipmentGross Property and equipment Machinery and equipment Leasehold improvements Accounting Standards Update [Domain] Accounting Standards Update [Axis] us-gaap_DueFromRelatedParties Due from Related Parties, Total us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage Cash flows from investing activities: Retained Earnings [Member] admt_WarrantyTerm Warranty Term (Day) The terms of a warranty. Electronic Products [Member] Information pertaining to type of product. Qol [Member] Information pertaining to Qol Devices Inc. Schedule Of Inventory [Table Text Block] Tabular disclosure of the amount of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. Current [Member] Information pertaining to inventory. us-gaap_RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction Long Term [Member Information pertaining to inventory. us-gaap_EquityMethodInvestments Equity Method Investments Additional Paid-in Capital [Member] admt_IncreaseDecreaseInOperatingLeaseLiability Payments of operating lease liability The increase (decrease) in operating lease liability during the period. Common Stock [Member] Related Party Transactions Disclosure [Text Block] us-gaap_IncomeTaxExpenseBenefit Total benefit from income taxes EX-101.PRE 10 admt-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Mar. 31, 2020	Jul. 14, 2020	Sep. 30, 2018
Document Information [Line Items]
Entity Registrant Name	ADM TRONICS UNLIMITED, INC.
Entity Central Index Key	0000849401
Current Fiscal Year End Date	--03-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		67,588,492
Entity Public Float			$ 11,490,044
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Title of 12(g) Security	COMMON STOCK, $.0005 PAR VALUE

XML 12 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Current assets:
Cash and cash equivalents	$ 1,438,714	$ 1,555,687
Accounts receivable, net of allowance for doubtful accounts of $225,000 and $160,000 at March 31, 2020 and 2019, respectively	860,539	916,844
Inventories	372,635	326,308
Prepaid expenses and other current assets	23,525	28,582
Total current assets	2,695,413	2,827,421
Property and equipment, net of accumulated depreciation of $145,602 and $108,099 at March 31, 2020 and 2019, respectively	57,958	95,461
Right-of-use asset	706,307
Accounts receivable-related party	330,090	330,090
Inventories - long-term portion	132,080	85,457
Intangible assets, net of accumulated amortization of $14,093 and $12,035 at March 31, 2020 and 2019, respectively	21,703	8,899
Other assets	90,538	90,764
Deferred tax asset	1,019,000	1,107,000
Total other assets	2,357,676	1,717,671
Total assets	5,053,089	4,545,092
Current liabilities:
Financing lease payable	21,458	31,196
Line of credit	30,000	169,885
Accounts payable	365,475	275,591
Accrued expenses and other current liabilities	136,188	150,549
Customer deposits	354,745	321,441
Due to stockholder	100,017	139,322
Total current liabilities	1,007,883	1,087,984
Long-term liabilities
Financing lease payable, net of current portion		22,450
Operating lease liability	706,307
Total long-term liabilities	706,307	22,450
Total liabilities	1,714,190	1,110,434
Stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,492 shares issued and outstanding	33,794	33,794
Additional paid-in capital	33,294,069	33,294,069
Accumulated deficit	(29,988,964)	(29,893,205)
Total stockholders' equity	3,338,899	3,434,658
Total liabilities and stockholders' equity	$ 5,053,089	$ 4,545,092

XML 13 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Accounts receivable, allowance for doubtful accounts	$ 225,000	$ 160,000
Property and equipment, accumulated depreciation	145,602	108,099
Intangible assets, accumulated amortization	$ 14,093	$ 12,035
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0005	$ 0.0005
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	67,588,492	67,588,492
Common stock, outstanding (in shares)	67,588,492	67,588,492

XML 14 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Net revenues	$ 3,485,992	$ 3,018,954
Cost of sales	1,911,972	1,454,700
Gross Profit	1,574,020	1,564,254
Operating expenses:
Research and development	589,373	673,855
Selling, general and administrative	1,005,354	1,243,011
Depreciation and amortization	22,682	22,108
Total operating expenses	1,617,409	1,938,974
Loss from operations	(43,389)	(374,720)
Other income (expense):
Interest income	25,576	26,948
Interest expense	(8,424)	(8,807)
Total other income (expense)	17,152	18,141
(Loss) before benefit from income taxes	(26,237)	(356,579)
Benefit from income taxes:
Current	(18,478)	(1,000)
Deferred	88,000	15,000
Total benefit from income taxes	69,522	14,000
Net (loss)	$ (95,759)	$ (342,579)
Basic and diluted earnings per common share: (in dollars per share)	$ 0	$ (0.01)
Weighted average shares of common stock outstanding - basic (in shares)	67,588,492	67,588,492
Weighted average shares of common stock outstanding - diluted (in shares)	67,588,492	67,588,492

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Stockholder's Equity (Deficiency) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Mar. 31, 2018	67,588,492
Balance at Mar. 31, 2018	$ 33,794	$ 33,294,069	$ (29,550,626)	$ 3,777,237
Net (loss)			(342,579)	(342,579)
Balance (in shares) at Mar. 31, 2019	67,588,492
Balance at Mar. 31, 2019	$ 33,794	33,294,069	(29,893,205)	3,434,658
Net (loss)			(95,759)	(95,759)
Balance (in shares) at Mar. 31, 2020	67,588,492
Balance at Mar. 31, 2020	$ 33,794	$ 33,294,069	$ (29,988,964)	$ 3,338,899

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net (loss)	$ (95,759)	$ (342,579)
Adjustments to reconcile net income (loss) to net cash (used in) operating activities:
Depreciation and amortization	39,559	39,055
Write-off of inventories	136,465	131,089
Bad debt	65,000	35,000
Deferred taxes	88,000	(15,000)
Non-cash operating lease expense	64,792
Non-cash interest expense	37,083
(Increase) decrease in operating assets:
Accounts receivable	(8,695)	(74,441)
Inventories	(229,415)	(230,780)
Prepaid expenses and other current assets	5,283	(15,726)
(Increase) decrease in operating liabilities:
Accounts payable	89,884	(11,373)
Customer deposits	33,304	199,274
Accrued expenses and other current liabilities	(14,361)	1,167
Due to stockholder	(39,305)	8,771
Payments of operating lease liability	(101,875)
Net cash provided by (used in) operating activities	69,960	(275,543)
Cash flows from investing activities:
Purchase of patents	(14,860)
Net cash (used in) investing activities	(14,860)
Cash flows from financing activities:
Proceeds from line of credit	170,000	386,000
Repayments of line of credit	(309,885)	(216,115)
Repayments of financing lease payable	(32,188)	(32,187)
Net cash provided by (used in) financing activities	(172,073)	137,698
Net (decrease) in cash and cash equivalents	(116,973)	(137,845)
Cash and cash equivalents - beginning of year	1,555,687	1,693,532
Cash and cash equivalents - end of year	1,438,714	1,555,687
Cash paid for:
Interest	8,424	8,807
Non-cash operating activities:
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842	$ 771,098

XML 17 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Nature of Business	12 Months Ended
Note 1 - Nature of Business	Mar. 31, 2020
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 – NATURE OF BUSINESS ADM Tronics Unlimited, Inc. ("we", "us", "the Company" or "ADM"), was incorporated under the laws of the state of Delaware on November 24, 1969. We are a manufacturing and engineering concern whose principal lines of business are the design, manufacture and sale of electronics of our own products or on a contract manufacturing basis; the production and sale of chemical and antistatic products; and, research, development and engineering services. Electronic equipment is manufactured in accordance with customer specifications on a contract basis. Our electronic device product line consists principally of proprietary devices used in diagnostics and therapeutics of humans and animals and electronic controllers for spas and hot tubs. These products are sold to customers located principally in the United States. We are registered with the FDA as a contract manufacturing facility and we manufacture medical devices for customers in accordance with their designs and specifications. Our chemical product line is principally comprised of water-based chemical products used in the food packaging and converting industries, and anti-static conductive paints, coatings and other products. These products are sold to customers located in the United States, Australia, Asia and Europe. We also provide research, development, regulatory and engineering services to customers. Our Sonotron Medical Systems, Inc. subsidiary (“Sonotron”) is involved in medical electronic therapeutic technology.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Significant Accounting Policies [Text Block]

NOTE

- SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

USE OF ESTIMATES

FAIR VALUE OF FINANCIAL INSTRUMENTS

For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.

CASH AND CASH EQUIVALENTS

Cash equivalents are comprised of certain highly liquid investments with original maturities of

three

months or less when purchased. We maintain our cash in bank deposit accounts, which at times,

may

exceed federally insured limits. We have

not

experienced any losses to date as a result of this policy. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of

$250,000

per institution. At

March 31, 2020,

approximately

$1,293,000

exceeded the FDIC limit.

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

not

be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will

not

be collected. Management provides for probable uncollectible amounts through a charge to expenses and a credit to a valuation allowance, based on its assessment of the current status of individual accounts. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable. Allowance for doubtful accounts was increased for the fiscal year ended

March 31, 2020

$225,000,

compared to

$160,000

March 31, 2019.

REVENUE RECOGNITION

ELECTRONICS:

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited

-day warranty on our electronics products and contract manufacturing and a limited

-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have

other post shipment obligations. Based on prior experience,

amounts have been accrued for potential warranty costs and actual costs were less than

$2,000

for each of the fiscal years ended

March 31, 2020

and

2019.

For contract manufacturing, revenues are recognized after shipment of the completed products.

$216,000

as of

March 31, 2019

were recognized as revenues during the year ended

March 31, 2020.

CHEMICAL PRODUCTS:

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when

right of return exists.

ENGINEERING SERVICES

All revenue is recognized net of discounts.

WARRANTY LIABILITIES

The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that

warranty liability is required as of the consolidated balance sheet dates. However, the Company periodically reviews the adequacy of its product warranties and will record an accrued warranty reserve if necessary.

INVENTORIES

Inventories are stated at the lower of cost (

first

-in,

first

-out method) and net realizable value. Inventories that are expected to be sold within

one

operating cycle (

year) are classified as a current asset. Inventories that are

not

expected to be sold within

year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off annually based on prior and expected future usage.

PROPERTY AND EQUIPMENT

We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over

five

seven

years, the estimated useful lives of the property and equipment.

INTANGIBLE ASSETS

Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount

may

not

be recoverable. In reviewing for impairment, the Company compares the carrying value of the relevant asset to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and its carrying value.

ADVERTISING COSTS

Advertising costs are expensed as incurred and amounted to

$41,353

and

$59,877

for the fiscal years ended

March 31, 2020

and

2019,

respectively.

SHIPPING AND HANDLING COSTS

Shipping and handling costs incurred for the years ended

March 31, 2020

and

2019

were approximately

$3,153

and

$3,754,

respectively. Such costs are included in selling, general, and administrative expenses in the accompanying consolidated statements of operations.

INCOME TAXES

not

be realized.

not

sustain the position following an audit. For tax positions meeting the more-likely-than-

not

threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than

percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended

March 31,

as follows:

Jurisdiction	Fiscal Year
Federal	2015 and beyond
New Jersey	2014 and beyond

There are currently

tax years under examination by any major tax jurisdictions.

The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of

March 31, 2020,

and

2019,

the Company has

accrued interest or penalties related to uncertain tax positions.

NET EARNINGS PER SHARE

Per share basic and diluted (loss) amounted to (

$0.00

) and $(

0.01

) for the fiscal years ended

March 31, 2020

and

2019,

respectively.

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current year presentation.

RECENT ACCOUNTING PRONOUNCEMENTS

Lease Accounting

. In

February 2016,

the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changes financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of

April 1, 2019,

using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (

) whether any expired or existing contracts are or contain leases, (

) the lease classification for any expired or existing leases, and (

) the initial direct costs for any existing leases.

twelve

months or less and does

not

contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred.

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning

April 1, 2019

when the Company recognized (a) a lease liability of

$771,098,

which represents the present value of the remaining lease payments of

$967,344,

discounted using the Company's incremental borrowing rate of

and (b) the related right-of-use asset of

$771,098

which represents the lease liability. Prior periods were

not

restated. Adoption of this standard had

change on financing leases previously subject to capital lease treatment under ASC Topic

840,

Leases. See Note

for further discussion of leases.

June 2016,

the FASB issued ASU-

2016

“Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are

not

accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after

December 15, 2019.

The Company is evaluating the potential impact on the Company’s consolidated financial statements.

Management does

not

believe that any other recently issued, but

not

yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Inventories

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Inventory Disclosure [Text Block]

NOTE

- INVENTORIES

Inventories at

March 31, 2020

consisted of the following:

	Current		Long Term		Total
Raw materials	$	289,369	$	121,013	$	410,382
Finished goods		83,266		11,067		94,333
Totals	$	372,635	$	132,080	$	504,715

Inventories at

March 31, 2019

consisted of the following:

	Current		Long Term		Total
Raw materials	$	273,039	$	84,721	$	357,760
Finished goods		53,269		736		54,005
Totals	$	326,308	$	85,457	$	411,765

XML 20 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Property and Equipment

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

NOTE

- PROPERTY AND EQUIPMENT

Property and equipment as of

March 31, 2020

and

2019

is as follows:

	2020			2019
Machinery and equipment	$	199,810		$	199,810
Leasehold improvements		3,750			3,750
		203,560			203,560

Accumulated depreciation and amortization		(145,602	)		(108,099	)

Property and equipment, net	$	57,958		$	95,461

Depreciation and amortization expense related to property and equipment amounted to

$37,503

and

$37,659

for the years ended

March 31, 2020

and

2019,

respectively.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

NOTE

- INTANGIBLE ASSETS

Intangible assets are being amortized using the straight-line method over periods ranging from

years with a weighted average remaining life of approximately

years.

	March 31, 2020										March 31, 2019
	Cost		Accumulated Amortization			Net Carrying Amount		Amortization Period (Years)			Cost		Accumulated Amortization			Net Carrying Amount		Amortization Period (Years)
Patents & Trademarks	$	35,794	$	(14,091	)	$	21,703	10	-	15	$	20,934	$	(12,035	)	$	8,899		15

Amortization expense was

$2,056

for each of the years ended

March 31, 2020

and

2019.

Estimated aggregate future amortization expense related to intangible assets is as follows:

For the fiscal years ended March 31,
2021	$	2,882
2022		2,882
2023		2,882
2024		2,882
2025		2,465
Thereafter		7,710
	$	21,703

XML 22 R12.htm IDEA: XBRL DOCUMENT

Note 6 - Accounts Receivable - Related Party	12 Months Ended
Note 6 - Accounts Receivable - Related Party	Mar. 31, 2020
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 6 – ACCOUNTS RECEIVABLE - RELATED PARTY The Company has a $75,000 investment for 23.2% of Qol Devices Inc. (Qol), which is carried at cost and reported as a component of other assets in the accompanying consolidated balance sheets. The Company provided $330,090 in engineering services to Qol during the year March 31, 2018. Qol owes the Company $330,090 as of March 31, 2020.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Line of Credit	12 Months Ended
Note 7 - Line of Credit	Mar. 31, 2020
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 7 – LINE OF CREDIT On June 15, 2018, the Company obtained an unsecured revolving line of credit, with a limit of $400,000. The line expires May 15, 2021 , renewing automatically every year. The Company is required to make monthly interest payments, at a rate of 5.37%. Any unpaid principal will be due upon maturity. As of March 31, 2020 and 2019, the outstanding balance was $30,000 and $169,885, respectively.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Leases

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Lessee, Operating and Finance Leases [Text Block]

NOTE

– LEASES

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on

June 30, 2028.

The Company The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of

March 31, 2020:

For the Years Ending March 31,
2021	$	101,875
2022		101,875
2023		101,875
2024		105,625
2025		106,875
Thereafter		347,344
		865,469
Less: Amount attributable to imputed interest		(159,161	)
Net liability at March 31, 2020	$	706,307

Weighted average remaining lease term (in years)		8.3
Weighted average discount rate		5.00	%

Rent and real estate tax expense for all facilities for the years ended

March 31, 2020

and

2019

was approximately

$135,000

and

$132,000,

respectively, and are reported as a component of cost of sales and selling, general and administrative expenses in the accompanying statement of operations. The Company paid in

$101,875

in lease payments during the year.

During

September 2016

the Company leased equipment with a cost of approximately

$129,000,

under provisions of various long-term financing leases whereby the minimum lease payments have been capitalized. Accumulated depreciation at

March 31, 2020

is approximately

$88,000.

The leases expire over various years through

2021.

Depreciation of the leased assets is included in depreciation and amortization expense. The lease obligations are secured by the leased assets.

Future minimum lease payments under the above financing leases, as of

March 31, 2020,

are approximately as follows:

For the Years Ending March 31,
2021	$	23,000
Less: Amount attributable to imputed interest		2,000

Present value of minimum lease payments		21,000
Less: Current maturities		21,000

	$	-

XML 25 R15.htm IDEA: XBRL DOCUMENT

Note 9 - Concentrations	12 Months Ended
Note 9 - Concentrations	Mar. 31, 2020
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE 9 – CONCENTRATIONS During the year ended March 31, 2020, one customer accounted for 48% of our net revenue. During the year ended March 31, 2019, two customers accounted for 58% of our net revenues. As of March 31, 2020, three customers accounted for 83% of our accounts receivable. As of March 31, 2019, two customers accounted for 88% of our accounts receivable. The loss of these major customers could have a material impact on our operations and cash flow. The Company’s customer base is comprised of foreign and domestic entities with diverse demographics. Revenues from foreign customers represented $324,596 of our net revenue or 9% for the year ended March 31, 2020. Revenues from foreign customers represented $364,418 of net revenues or 12% for the year ended March 31, 2019.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Note 10 - Segment Information

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

NOTE

- SEGMENT INFORMATION

Information about segments is as follows:

	Chemical			Electronics			Engineering		Total
Year ended March 31, 2020
Revenue from external customers	$	1,368,365		$	1,400,918		$	716,709	$	3,485,992
Segment operating income (loss)	$	58,477		$	(147,023	)	$	45,157	$	(43,389	)

Year ended March 31, 2019
Revenue from external customers	$	1,318,814		$	730,634		$	969,506	$	3,018,954
Segment operating income (loss)	$	(81,849	)	$	(403,099	)	$	110,228	$	(374,720	)


Total assets at March 31, 2020	$	5,053,89		$	1,970,705		$	1,061,149	$	5,053,089

Total assets at March 31, 2019	$	1,985,501		$	1,099,983		$	1,459,608	$	4,545,092

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

XML 27 R17.htm IDEA: XBRL DOCUMENT

Note 11 - Disaggregated Net Revenues and Segment Information

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

NOTE

- DISAGGREGATED NET REVENUES AND SEGMENT INFORMATION

The following tables show the Company's net revenues disaggregated by reportable segment and by product and service type:

	Twelve Months Ended March 31,
	2020		2019
Net Revenue in the US
Chemical	$	1,043,769	$	954,396
Electronics		1,400,918		730,634
Engineering		716,709		969,506
		3,161,396		2,654,536

Net Revenue outside the US
Chemical		324,596		364,418
Electronics		-		-
Engineering		-		-
		324,596		364,418

Total Revenues	$	3,485,992	$	3,018,954

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

+ Details

XML 28 R18.htm IDEA: XBRL DOCUMENT

Note 12 - Income Taxes

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Income Tax Disclosure [Text Block]

NOTE

- INCOME TAXES

March 31, 2020,

the Company had federal and state net operating loss carry-forwards, (NOL’s) of approximately

$2,468,000,

which are due to expire through fiscal

2034.

These NOLs

may

be used to offset future taxable income through their respective expiration dates and thereby reduce or eliminate our federal and state income taxes otherwise payable. A valuation allowance is provided when it is more likely than

not

that some portion or all of the deferred tax assets will

not

be realized. Ultimate utilization of such NOL’s and credits is dependent upon the Company’s ability to generate taxable income in future periods and

may

be significantly curtailed if a significant change in ownership occurs.

Significant components of deferred tax assets are as follows as of

March 31, 2020

and

2019:

	2020		2019

Net operating loss carry-forward	$	536,000	$	637,000
Research & development tax credit carry-forward		429,000		429,000
Other		54,000		41,000

Deferred tax asset, net	$	1,019,000	$	1,107,000

The benefit from (provision) for income taxes for the years ended at

March 31, 2020

and

2019

differs from that amount using the statutory federal income tax rate as follows:

	2020		2019

Statutory federal income tax rate		21%		21%
State Taxes, net of federal		7%		-
Other		(-228%)		(17%)
Effective income tax rate		(200%)		4%

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

XML 29 R19.htm IDEA: XBRL DOCUMENT

Note 13 - Stock Based Compensation

12 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

NOTE

– STOCK BASED COMPENSATION

September 2, 2015,

ADM granted

3,000,000

stock options to employees at an exercise price of

$0.20

per option and with a term of

three

years. The options were valued at

$598,699

using the Black Scholes option pricing model with the following assumptions: risk free interest rate of

2.03%,

volatility of

353%,

estimated useful life of

years and dividend rate of

0%.

The options expired during the year ended

March 31, 2019.

January 13, 2020,

ADM granted

300,000

stock options to

one

employee at an exercise price of

$0.20

per option with a term of

two

years subject to vesting in

four

equal amounts of

75,000

share every

six

months. The options were valued at

$35,206

using the Black Scholes option pricing model with the following assumptions: risk free interest rate of

1.58%,

volatility of

132%,

estimated useful life of

years and dividend rate of

0%.

The following table summarizes information on all common share purchase options issued by us as of

March 31, 2020

and

2019.

	2020				2019
	# of Shares		Weighted		# of Shares			Weighted
			Average					Average
			Exercise					Exercise
			Price					Price

Outstanding, beginning of year		-	$	-		3,000,000		$	0.20

Issued		300,000		0.20		-			-

Exercised		-		-		-			-

Expired		-		-		(3,000,000	)		-

Outstanding, end of year		300,000	$	0.20		-			-

Exercisable, end of year		-	$	-		-			-

As of

March 31, 2020,

there was

$35,206

of unrecognized compensation costs, which is expected to be recognized as follows:

For the years ending March 31,	Amount
2021	$	11,735
2022		11,735
2023		11,736
	$	35,206

XML 30 R20.htm IDEA: XBRL DOCUMENT

Note 14 - Legal Proceedings	12 Months Ended
Note 14 - Legal Proceedings	Mar. 31, 2020
Notes to Financial Statements
Legal Matters and Contingencies [Text Block]	NOTE 14 – LEGAL PROCEEDINGS In November 2019, the Company filed a civil suit in the Superior Court of New Jersey against an accounting firm seeking a declaratory judgement from the court that no sum is due to the accounting firm, plus damages, attorney's fees and costs with respect to the foregoing. This matter was settled by mutual agreement for the Company to pay $7,500 to the defendant. All claims were dismissed by both parties on June 2, 2020. We are involved, from time to time, in litigation and proceedings arising out of the ordinary course of business. Other than the foregoing, there are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Note 15 - Subsequent Events	12 Months Ended
Note 15 - Subsequent Events	Mar. 31, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 15 – SUBSEQUENT EVENTS The World Health Organization characterized the COVID- 19 virus as a global pandemic on March 11, 2020. The COVID- 19 global pandemic has negatively affected the global economy. We began to see the impact of COVID- 19 during our fourth quarter of fiscal 2020 with certain of our customers being required to close and/or suspend their own operations due to the COVID- 19 pandemic. As a result, net sales and production levels during the fourth quarter of fiscal 2020 and the first quarter of fiscal 2021 were reduced, thus impacting our results of operations during these quarters. The extent of the impact of the COVID- 19 pandemic on our business, financial results and liquidity will depend on future developments and the financial condition of our customers that we may not be able to foresee. Any of these factors, and other factors beyond our control, can adversely impact our results for the first quarter of fiscal 2021, as well as the full fiscal year, and such impact may be material. At this time, management is unable to quantify its potential effects on the operations and financial performance of the Company. In May 2020, under the U.S. Small Business Administration Paycheck Protection Program, the Company received approximately $381,000. The loan will be forgiven if the funds are used for payroll costs, interest on mortgages, rent and utilities, with at least 60% being used for payroll. Forgiveness will be reduced if full-time headcount declines, or if salaries and wages decrease. Loan payments will also be deferred for six months. No collateral or personal guarantees were required for the loan. The loan has an interest rate of 1% and a maturity of two years, which can be extended up to five years if the Company and the lender agree. We evaluated all subsequent events from the date of the consolidated balance sheet through the issuance date of these consolidated financial statements and determined that there are no events or transactions occurring during the subsequent event reporting period which require recognition or disclosure in the consolidated financial statements.

XML 32 R22.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

12 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

PRINCIPLES OF CONSOLIDATION

Use of Estimates, Policy [Policy Text Block]

USE OF ESTIMATES

Fair Value of Financial Instruments, Policy [Policy Text Block]

FAIR VALUE OF FINANCIAL INSTRUMENTS

For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.

Cash and Cash Equivalents, Policy [Policy Text Block]

CASH AND CASH EQUIVALENTS

Cash equivalents are comprised of certain highly liquid investments with original maturities of

three

months or less when purchased. We maintain our cash in bank deposit accounts, which at times,

may

exceed federally insured limits. We have

not

$250,000

per institution. At

March 31, 2020,

approximately

$1,293,000

exceeded the FDIC limit.

Receivable [Policy Text Block]

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

not

be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will

not

March 31, 2020

$225,000,

compared to

$160,000

March 31, 2019.

Revenue [Policy Text Block]

REVENUE RECOGNITION

ELECTRONICS:

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited

-day warranty on our electronics products and contract manufacturing and a limited

-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have

other post shipment obligations. Based on prior experience,

amounts have been accrued for potential warranty costs and actual costs were less than

$2,000

for each of the fiscal years ended

March 31, 2020

and

2019.

For contract manufacturing, revenues are recognized after shipment of the completed products.

$216,000

as of

March 31, 2019

were recognized as revenues during the year ended

March 31, 2020.

CHEMICAL PRODUCTS:

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when

right of return exists.

ENGINEERING SERVICES

All revenue is recognized net of discounts.

Guarantees, Indemnifications and Warranties Policies [Policy Text Block]

WARRANTY LIABILITIES

The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that

Inventory, Policy [Policy Text Block]

INVENTORIES

Inventories are stated at the lower of cost (

first

-in,

first

-out method) and net realizable value. Inventories that are expected to be sold within

one

operating cycle (

year) are classified as a current asset. Inventories that are

not

expected to be sold within

year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off annually based on prior and expected future usage.

Property, Plant and Equipment, Policy [Policy Text Block]

PROPERTY AND EQUIPMENT

We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over

five

seven

years, the estimated useful lives of the property and equipment.

Intangible Assets, Finite-Lived, Policy [Policy Text Block]

INTANGIBLE ASSETS

Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount

may

not

Advertising Cost [Policy Text Block]

ADVERTISING COSTS

Advertising costs are expensed as incurred and amounted to

$41,353

and

$59,877

for the fiscal years ended

March 31, 2020

and

2019,

respectively.

Shipping And Handling Costs [Policy Text Block]

SHIPPING AND HANDLING COSTS

Shipping and handling costs incurred for the years ended

March 31, 2020

and

2019

were approximately

$3,153

and

$3,754,

respectively. Such costs are included in selling, general, and administrative expenses in the accompanying consolidated statements of operations.

Income Tax, Policy [Policy Text Block]

INCOME TAXES

not

be realized.

not

sustain the position following an audit. For tax positions meeting the more-likely-than-

not

threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than

percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended

March 31,

as follows:

Jurisdiction	Fiscal Year
Federal	2015 and beyond
New Jersey	2014 and beyond

There are currently

tax years under examination by any major tax jurisdictions.

The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of

March 31, 2020,

and

2019,

the Company has

accrued interest or penalties related to uncertain tax positions.

Earnings Per Share, Policy [Policy Text Block]

NET EARNINGS PER SHARE

Per share basic and diluted (loss) amounted to (

$0.00

) and $(

0.01

) for the fiscal years ended

March 31, 2020

and

2019,

respectively.

Reclassification, Comparability Adjustment [Policy Text Block]

RECLASSIFICATION

Certain items in the prior financial statements have been reclassified to conform to the current year presentation.

New Accounting Pronouncements, Policy [Policy Text Block]

RECENT ACCOUNTING PRONOUNCEMENTS

Lease Accounting

. In

February 2016,

April 1, 2019,

) whether any expired or existing contracts are or contain leases, (

) the lease classification for any expired or existing leases, and (

) the initial direct costs for any existing leases.

twelve

months or less and does

not

contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred.

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning

April 1, 2019

when the Company recognized (a) a lease liability of

$771,098,

which represents the present value of the remaining lease payments of

$967,344,

discounted using the Company's incremental borrowing rate of

and (b) the related right-of-use asset of

$771,098

which represents the lease liability. Prior periods were

not

restated. Adoption of this standard had

change on financing leases previously subject to capital lease treatment under ASC Topic

840,

Leases. See Note

for further discussion of leases.

June 2016,

the FASB issued ASU-

2016

“Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investments in leases that are

not

December 15, 2019.

The Company is evaluating the potential impact on the Company’s consolidated financial statements.

Management does

not

believe that any other recently issued, but

not

yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements.

XML 33 R23.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Summary of Income Tax Examinations [Table Text Block]

Jurisdiction	Fiscal Year
Federal	2015 and beyond
New Jersey	2014 and beyond

XML 34 R24.htm IDEA: XBRL DOCUMENT

Note 3 - Inventories (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Schedule Of Inventory [Table Text Block]

	Current		Long Term		Total
Raw materials	$	289,369	$	121,013	$	410,382
Finished goods		83,266		11,067		94,333
Totals	$	372,635	$	132,080	$	504,715

	Current		Long Term		Total
Raw materials	$	273,039	$	84,721	$	357,760
Finished goods		53,269		736		54,005
Totals	$	326,308	$	85,457	$	411,765

XML 35 R25.htm IDEA: XBRL DOCUMENT

Note 4 - Property and Equipment (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Property, Plant and Equipment [Table Text Block]

	2020			2019
Machinery and equipment	$	199,810		$	199,810
Leasehold improvements		3,750			3,750
		203,560			203,560

Accumulated depreciation and amortization		(145,602	)		(108,099	)

Property and equipment, net	$	57,958		$	95,461

XML 36 R26.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	March 31, 2020										March 31, 2019
	Cost		Accumulated Amortization			Net Carrying Amount		Amortization Period (Years)			Cost		Accumulated Amortization			Net Carrying Amount		Amortization Period (Years)
Patents & Trademarks	$	35,794	$	(14,091	)	$	21,703	10	-	15	$	20,934	$	(12,035	)	$	8,899		15

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

For the fiscal years ended March 31,
2021	$	2,882
2022		2,882
2023		2,882
2024		2,882
2025		2,465
Thereafter		7,710
	$	21,703

XML 37 R27.htm IDEA: XBRL DOCUMENT

Note 8 - Leases (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

For the Years Ending March 31,
2021	$	101,875
2022		101,875
2023		101,875
2024		105,625
2025		106,875
Thereafter		347,344
		865,469
Less: Amount attributable to imputed interest		(159,161	)
Net liability at March 31, 2020	$	706,307

Weighted average remaining lease term (in years)		8.3
Weighted average discount rate		5.00	%

Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]

For the Years Ending March 31,
2021	$	23,000
Less: Amount attributable to imputed interest		2,000

Present value of minimum lease payments		21,000
Less: Current maturities		21,000

	$	-

XML 38 R28.htm IDEA: XBRL DOCUMENT

Note 10 - Segment Information (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Chemical			Electronics			Engineering		Total
Year ended March 31, 2020
Revenue from external customers	$	1,368,365		$	1,400,918		$	716,709	$	3,485,992
Segment operating income (loss)	$	58,477		$	(147,023	)	$	45,157	$	(43,389	)

Year ended March 31, 2019
Revenue from external customers	$	1,318,814		$	730,634		$	969,506	$	3,018,954
Segment operating income (loss)	$	(81,849	)	$	(403,099	)	$	110,228	$	(374,720	)


Total assets at March 31, 2020	$	5,053,89		$	1,970,705		$	1,061,149	$	5,053,089

Total assets at March 31, 2019	$	1,985,501		$	1,099,983		$	1,459,608	$	4,545,092

XML 39 R29.htm IDEA: XBRL DOCUMENT

Note 11 - Disaggregated Net Revenues and Segment Information (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Revenue from External Customers by Geographic Areas [Table Text Block]

	Twelve Months Ended March 31,
	2020		2019
Net Revenue in the US
Chemical	$	1,043,769	$	954,396
Electronics		1,400,918		730,634
Engineering		716,709		969,506
		3,161,396		2,654,536

Net Revenue outside the US
Chemical		324,596		364,418
Electronics		-		-
Engineering		-		-
		324,596		364,418

Total Revenues	$	3,485,992	$	3,018,954

XML 40 R30.htm IDEA: XBRL DOCUMENT

Note 12 - Income Taxes (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	2020		2019

Net operating loss carry-forward	$	536,000	$	637,000
Research & development tax credit carry-forward		429,000		429,000
Other		54,000		41,000

Deferred tax asset, net	$	1,019,000	$	1,107,000

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	2020		2019

Statutory federal income tax rate		21%		21%
State Taxes, net of federal		7%		-
Other		(-228%)		(17%)
Effective income tax rate		(200%)		4%

XML 41 R31.htm IDEA: XBRL DOCUMENT

Note 13 - Stock Based Compensation (Tables)

12 Months Ended

Mar. 31, 2020

Notes Tables

Share-based Payment Arrangement, Option, Activity [Table Text Block]

	2020				2019
	# of Shares		Weighted		# of Shares			Weighted
			Average					Average
			Exercise					Exercise
			Price					Price

Outstanding, beginning of year		-	$	-		3,000,000		$	0.20

Issued		300,000		0.20		-			-

Exercised		-		-		-			-

Expired		-		-		(3,000,000	)		-

Outstanding, end of year		300,000	$	0.20		-			-

Exercisable, end of year		-	$	-		-			-

Schedule of Unrecognized Compensation Costs [Table Text Block]

For the years ending March 31,	Amount
2021	$	11,735
2022		11,735
2023		11,736
	$	35,206

XML 42 R32.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Apr. 01, 2019
Cash, Uninsured Amount	$ 1,293,000
Accounts Receivable, Allowance for Credit Loss, Ending Balance	225,000	$ 160,000
Contract with Customer, Liability, Revenue Recognized	216,000
Advertising Expense	41,353	59,877
Shipping and Handling Costs	3,153	3,754
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	$ 0	$ 0
Earnings Per Share, Basic and Diluted, Total (in dollars per share)	$ 0	$ (0.01)
Operating Lease, Liability, Total	$ 706,307
Lessee, Operating Lease, Liability, to be Paid, Total	$ 865,469
Operating Lease, Weighted Average Discount Rate, Percent	5.00%
Operating Lease, Right-of-Use Asset	$ 706,307
Accounting Standards Update 2016-02 [Member]
Operating Lease, Liability, Total			$ 771,098
Lessee, Operating Lease, Liability, to be Paid, Total			$ 967,344
Operating Lease, Weighted Average Discount Rate, Percent			5.00%
Operating Lease, Right-of-Use Asset			$ 771,098
Maximum [Member]
Product Warranty Expense	$ 2,000	$ 2,000
Property, Plant and Equipment, Useful Life (Year)	7 years
Minimum [Member]
Property, Plant and Equipment, Useful Life (Year)	5 years
Electronic Products [Member]
Warranty Term (Day)	90 days
Electronic Controllers for Spas and Hot Tubs [Member]
Warranty Term (Day)	5 years

XML 43 R33.htm IDEA: XBRL DOCUMENT

Note 2 - Significant Accounting Policies - Income Tax Returns Jurisdictions Subject to Examination (Details)	12 Months Ended
	Mar. 31, 2020
Internal Revenue Service (IRS) [Member] \| Domestic Tax Authority [Member]
Open tax years	2015 2016 2017 2018 2019 2020
New Jersey Division of Taxation [Member] \| State and Local Jurisdiction [Member]
Open tax years	2014 2015 2016 2017 2018 2019 2020

XML 44 R34.htm IDEA: XBRL DOCUMENT

Note 3 - Inventories - Summary of Inventory (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Raw materials	$ 410,382	$ 357,760
Finished goods	94,333	54,005
Totals	504,715	411,765
Current [Member]
Raw materials	289,369	273,039
Finished goods	83,266	53,269
Totals	372,635	326,308
Long Term [Member
Raw materials	121,013	84,721
Finished goods	11,067	736
Totals	$ 132,080	$ 85,457

XML 45 R35.htm IDEA: XBRL DOCUMENT

Note 4 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Depreciation, Total	$ 37,503	$ 37,659

XML 46 R36.htm IDEA: XBRL DOCUMENT

Note 4 - Property and Equipment - Property and Equipment (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Machinery and equipment	$ 199,810	$ 199,810
Leasehold improvements	3,750	3,750
Property and equipment	203,560	203,560
Accumulated depreciation and amortization	(145,602)	(108,099)
Property and equipment, net	$ 57,958	$ 95,461

XML 47 R37.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets (Details Textual) - USD ($)	12 Months Ended
Note 5 - Intangible Assets (Details Textual) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Finite-Lived Intangible Assets, Remaining Amortization Period (Year)	6 years
Amortization of Intangible Assets, Total	$ 2,056	$ 2,056
Minimum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	10 years
Maximum [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	15 years

XML 48 R38.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets - Intangible Assets (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accumulated Amortization	$ (14,093)	$ (12,035)
Net Carrying Amount	21,703	8,899
Patents And Trademarks [Member]
Cost	35,794	20,934
Accumulated Amortization	(14,091)	(12,035)
Net Carrying Amount	$ 21,703	$ 8,899
Weighted Average Amortization Period (Year)		15 years
Patents And Trademarks [Member] \| Minimum [Member]
Weighted Average Amortization Period (Year)	10 years
Patents And Trademarks [Member] \| Maximum [Member]
Weighted Average Amortization Period (Year)	15 years

XML 49 R39.htm IDEA: XBRL DOCUMENT

Note 5 - Intangible Assets - Estimated Aggregate Future Amortization Expense (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
2021	$ 2,882
2022	2,882
2023	2,882
2024	2,882
2025	2,465
Thereafter	7,710
Finite-Lived Intangible Assets, Net, Ending Balance	$ 21,703	$ 8,899

XML 50 R40.htm IDEA: XBRL DOCUMENT

Note 6 - Accounts Receivable - Related Party (Details Textual) - USD ($)	12 Months Ended
	Mar. 31, 2018	Mar. 31, 2020
Qol [Member]
Due from Related Parties, Total		$ 330,090
Qol [Member] \| Engineering Services [Member]
Related Party Transaction, Amounts of Transaction	$ 330,090
Qol [Member]
Equity Method Investments		$ 75,000
Equity Method Investment, Ownership Percentage		23.20%

XML 51 R41.htm IDEA: XBRL DOCUMENT

Note 7 - Line of Credit (Details Textual) - Revolving Credit Facility [Member] - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Jun. 15, 2018
Line of Credit Facility, Maximum Borrowing Capacity			$ 400,000
Line of Credit Facility, Expiration Date	May 15, 2021
Debt Instrument, Interest Rate, Stated Percentage	5.37%
Short-term Debt, Total	$ 30,000	$ 169,885

XML 52 R42.htm IDEA: XBRL DOCUMENT

Note 8 - Leases (Details Textual) - USD ($)	12 Months Ended
Note 8 - Leases (Details Textual) - USD ($)	Mar. 31, 2020	Mar. 31, 2019	Sep. 30, 2016
Operating Lease, Payments	$ 101,875
Finance Lease, Right-of-Use Asset			$ 129,000
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation	88,000
Selling, General and Administrative Expenses [Member]
Operating Lease, Expense	$ 135,000	$ 132,000

XML 53 R43.htm IDEA: XBRL DOCUMENT

Note 8 - Leases - Future Minimum Lease Payments for Operating Lease (Details)	Mar. 31, 2020 USD ($)
2021	$ 101,875
2022	101,875
2023	101,875
2024	105,625
2025	106,875
Thereafter	347,344
Lessee, Operating Lease, Liability, to be Paid, Total	865,469
Less: Amount attributable to imputed interest	(159,161)
Net liability at March 31, 2020	$ 706,307
Weighted average remaining lease term (in years) (Year)	8 years 109 days
Weighted average discount rate	5.00%

XML 54 R44.htm IDEA: XBRL DOCUMENT

Note 8 - Leases - Future Minimum Lease Payments for Financing Leases (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
2021	$ 23,000
Less: Amount attributable to imputed interest	2,000
Present value of minimum lease payments	21,000
Less: Current maturities	$ 21,458	$ 31,196

XML 55 R45.htm IDEA: XBRL DOCUMENT

Note 9 - Concentrations (Details Textual)	12 Months Ended
Note 9 - Concentrations (Details Textual)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)
Revenue from Contract with Customer, Including Assessed Tax	$ 3,485,992	$ 3,018,954
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| One Customer [Member]
Concentration Risk, Number of Customers	1
Concentration Risk, Percentage	48.00%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Two Customers [Member]
Concentration Risk, Number of Customers		2
Concentration Risk, Percentage		58.00%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Foreign Customers [Member]
Concentration Risk, Percentage	9.00%	12.00%
Revenue from Contract with Customer, Including Assessed Tax	$ 324,596	$ 364,418
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Two Customers [Member]
Concentration Risk, Number of Customers		2
Concentration Risk, Percentage		88.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Three Customers [Member]
Concentration Risk, Number of Customers	3
Concentration Risk, Percentage	83.00%

XML 56 R46.htm IDEA: XBRL DOCUMENT

Note 10 - Segment Information - Summary of Segment Information (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue from Contract with Customer, Including Assessed Tax	$ 3,485,992	$ 3,018,954
Segment operating income (loss)	(43,389)	(374,720)
Total assets	5,053,089	4,545,092
Chemical [Member]
Revenue from Contract with Customer, Including Assessed Tax	1,368,365	1,318,814
Segment operating income (loss)	58,477	(81,849)
Total assets	505,389	1,985,501
Electronics [Member]
Revenue from Contract with Customer, Including Assessed Tax	1,400,918	730,634
Segment operating income (loss)	(147,023)	(403,099)
Total assets	1,970,705	1,099,983
Engineering [Member]
Revenue from Contract with Customer, Including Assessed Tax	716,709	969,506
Segment operating income (loss)	45,157	110,228
Total assets	$ 1,061,149	$ 1,459,608

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

XML 57 R47.htm IDEA: XBRL DOCUMENT

Note 11 - Disaggregated Net Revenues and Segment Information - Net Revenue, Classified by Geography (Details) - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net revenues	$ 3,485,992	$ 3,018,954
Chemical [Member]
Net revenues	1,368,365	1,318,814
Electronics [Member]
Net revenues	1,400,918	730,634
Engineering [Member]
Net revenues	716,709	969,506
UNITED STATES
Net revenues	3,161,396	2,654,536
UNITED STATES \| Chemical [Member]
Net revenues	1,043,769	954,396
UNITED STATES \| Electronics [Member]
Net revenues	1,400,918	730,634
UNITED STATES \| Engineering [Member]
Net revenues	716,709	969,506
Non-US [Member]
Net revenues	324,596	364,418
Non-US [Member] \| Chemical [Member]
Net revenues	324,596	364,418
Non-US [Member] \| Electronics [Member]
Net revenues
Non-US [Member] \| Engineering [Member]
Net revenues

- Definition

+ References

+ Details

XML 58 R48.htm IDEA: XBRL DOCUMENT

Note 12 - Income Taxes (Details Textual)	Mar. 31, 2020 USD ($)
Operating Loss Carryforwards, Total	$ 2,468,000

XML 59 R49.htm IDEA: XBRL DOCUMENT

Note 12 - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Net operating loss carry-forward	$ 536,000	$ 637,000
Research & development tax credit carry-forward	429,000	429,000
Other	54,000	41,000
Deferred tax asset, net	$ 1,019,000	$ 1,107,000

XML 60 R50.htm IDEA: XBRL DOCUMENT

Note 12 - Income Taxes - Provision for Income Taxes (Details)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statutory federal income tax rate	21.00%	21.00%
State Taxes, net of federal	7.00%
Other	(228.00%)	(17.00%)
Effective income tax rate	(200.00%)	4.00%

XML 61 R51.htm IDEA: XBRL DOCUMENT

Note 13 - Stock Based Compensation (Details Textual) - USD ($)			12 Months Ended
	Jan. 13, 2020	Sep. 02, 2015	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	300,000	3,000,000	300,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)	$ 0.20	$ 0.20	$ 0.20
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	2 years	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 35,206	$ 598,699
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.58%	2.03%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	132.00%	353.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total			$ 35,206
Vesting in Four Equal Amount Every Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	75,000

XML 62 R52.htm IDEA: XBRL DOCUMENT

Note 13 - Stock Based Compensation - Summary of Stock Option Activity (Details) - $ / shares			12 Months Ended
	Jan. 13, 2020	Sep. 02, 2015	Mar. 31, 2020	Mar. 31, 2019
Outstanding, beginning of year (in shares)				3,000,000
Outstanding, weighted average exercise price (in dollars per share)				$ 0.20
Issued (in shares)	300,000	3,000,000	300,000
Issued, weighted average exercise price (in dollars per share)	$ 0.20	$ 0.20	$ 0.20
Exercised (in shares)
Exercised, weighted average exercise price (in dollars per share)
Expired (in shares)				(3,000,000)
Expired, weighted average exercise price (in dollars per share)
Outstanding, end of year (in shares)			300,000
Outstanding, weighted average exercise price (in dollars per share)			$ 0.20
Exercisable, end of year (in shares)
Exercisable, weighted average exercise price (in dollars per share)

XML 63 R53.htm IDEA: XBRL DOCUMENT

Note 13 - Stock Based Compensation - Unrecognized Compensation Costs (Details)	Mar. 31, 2020 USD ($)
2021	$ 11,735
2022	11,735
2023	11,736
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total	$ 35,206

XML 64 R54.htm IDEA: XBRL DOCUMENT

Note 14 - Legal Proceedings (Details Textual)	Jun. 02, 2020 USD ($)
Civil Suit Against Accounting Firm [Member] \| Subsequent Event [Member]
Litigation Settlement, Amount Awarded to Other Party	$ 7,500

XML 65 R55.htm IDEA: XBRL DOCUMENT

Note 15 - Subsequent Events (Details Textual)	1 Months Ended
Note 15 - Subsequent Events (Details Textual)	May 31, 2020 USD ($)
Loans from SBA PPP [Member] \| Subsequent Event [Member]
Proceeds from Issuance of Long-term Debt, Total	$ 381,000

EXCEL 66 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
! #L( &@ @ $(W >&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " *@^Y0%-1QY- ! "M( M$P @ $@W@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 ../P _ # 1 AX ! end XML 67 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 68 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 69 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 88 315 1 false 36 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.admtronics.com/20200331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.admtronics.com/20200331/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.admtronics.com/20200331/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.admtronics.com/20200331/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholder's Equity (Deficiency) (Unaudited) Sheet http://www.admtronics.com/20200331/role/statement-condensed-consolidated-statements-of-stockholders-equity-deficiency-unaudited Condensed Consolidated Statements of Stockholder's Equity (Deficiency) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.admtronics.com/20200331/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of Business Sheet http://www.admtronics.com/20200331/role/statement-note-1-nature-of-business Note 1 - Nature of Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Significant Accounting Policies Sheet http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies Note 2 - Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Inventories Sheet http://www.admtronics.com/20200331/role/statement-note-3-inventories Note 3 - Inventories Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Property and Equipment Sheet http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment Note 4 - Property and Equipment Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Intangible Assets Sheet http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets Note 5 - Intangible Assets Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Accounts Receivable - Related Party Sheet http://www.admtronics.com/20200331/role/statement-note-6-accounts-receivable-related-party Note 6 - Accounts Receivable - Related Party Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Line of Credit Sheet http://www.admtronics.com/20200331/role/statement-note-7-line-of-credit Note 7 - Line of Credit Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Leases Sheet http://www.admtronics.com/20200331/role/statement-note-8-leases Note 8 - Leases Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Concentrations Sheet http://www.admtronics.com/20200331/role/statement-note-9-concentrations Note 9 - Concentrations Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Segment Information Sheet http://www.admtronics.com/20200331/role/statement-note-10-segment-information Note 10 - Segment Information Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information Sheet http://www.admtronics.com/20200331/role/statement-note-11-disaggregated-net-revenues-and-segment-information Note 11 - Disaggregated Net Revenues and Segment Information Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Income Taxes Sheet http://www.admtronics.com/20200331/role/statement-note-12-income-taxes Note 12 - Income Taxes Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Stock Based Compensation Sheet http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation Note 13 - Stock Based Compensation Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Legal Proceedings Sheet http://www.admtronics.com/20200331/role/statement-note-14-legal-proceedings Note 14 - Legal Proceedings Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Subsequent Events Sheet http://www.admtronics.com/20200331/role/statement-note-15-subsequent-events Note 15 - Subsequent Events Notes 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.admtronics.com/20200331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies 22 false false R23.htm 022 - Disclosure - Note 2 - Significant Accounting Policies (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies-tables Note 2 - Significant Accounting Policies (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies 23 false false R24.htm 023 - Disclosure - Note 3 - Inventories (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-3-inventories-tables Note 3 - Inventories (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-3-inventories 24 false false R25.htm 024 - Disclosure - Note 4 - Property and Equipment (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment-tables Note 4 - Property and Equipment (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment 25 false false R26.htm 025 - Disclosure - Note 5 - Intangible Assets (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets-tables Note 5 - Intangible Assets (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets 26 false false R27.htm 026 - Disclosure - Note 8 - Leases (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-8-leases-tables Note 8 - Leases (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-8-leases 27 false false R28.htm 027 - Disclosure - Note 10 - Segment Information (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-10-segment-information-tables Note 10 - Segment Information (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-10-segment-information 28 false false R29.htm 028 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-11-disaggregated-net-revenues-and-segment-information-tables Note 11 - Disaggregated Net Revenues and Segment Information (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-11-disaggregated-net-revenues-and-segment-information 29 false false R30.htm 029 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-12-income-taxes 30 false false R31.htm 030 - Disclosure - Note 13 - Stock Based Compensation (Tables) Sheet http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation-tables Note 13 - Stock Based Compensation (Tables) Tables http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation 31 false false R32.htm 031 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies-details-textual Note 2 - Significant Accounting Policies (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies-tables 32 false false R33.htm 032 - Disclosure - Note 2 - Significant Accounting Policies - Income Tax Returns Jurisdictions Subject to Examination (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-2-significant-accounting-policies-income-tax-returns-jurisdictions-subject-to-examination-details Note 2 - Significant Accounting Policies - Income Tax Returns Jurisdictions Subject to Examination (Details) Details 33 false false R34.htm 033 - Disclosure - Note 3 - Inventories - Summary of Inventory (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-3-inventories-summary-of-inventory-details Note 3 - Inventories - Summary of Inventory (Details) Details 34 false false R35.htm 034 - Disclosure - Note 4 - Property and Equipment (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment-details-textual Note 4 - Property and Equipment (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment-tables 35 false false R36.htm 035 - Disclosure - Note 4 - Property and Equipment - Property and Equipment (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-4-property-and-equipment-property-and-equipment-details Note 4 - Property and Equipment - Property and Equipment (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Intangible Assets (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets-details-textual Note 5 - Intangible Assets (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets-tables 37 false false R38.htm 037 - Disclosure - Note 5 - Intangible Assets - Intangible Assets (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets-intangible-assets-details Note 5 - Intangible Assets - Intangible Assets (Details) Details 38 false false R39.htm 038 - Disclosure - Note 5 - Intangible Assets - Estimated Aggregate Future Amortization Expense (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-5-intangible-assets-estimated-aggregate-future-amortization-expense-details Note 5 - Intangible Assets - Estimated Aggregate Future Amortization Expense (Details) Details 39 false false R40.htm 039 - Disclosure - Note 6 - Accounts Receivable - Related Party (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-6-accounts-receivable-related-party-details-textual Note 6 - Accounts Receivable - Related Party (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-6-accounts-receivable-related-party 40 false false R41.htm 040 - Disclosure - Note 7 - Line of Credit (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-7-line-of-credit-details-textual Note 7 - Line of Credit (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-7-line-of-credit 41 false false R42.htm 041 - Disclosure - Note 8 - Leases (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-8-leases-details-textual Note 8 - Leases (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-8-leases-tables 42 false false R43.htm 042 - Disclosure - Note 8 - Leases - Future Minimum Lease Payments for Operating Lease (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-8-leases-future-minimum-lease-payments-for-operating-lease-details Note 8 - Leases - Future Minimum Lease Payments for Operating Lease (Details) Details 43 false false R44.htm 043 - Disclosure - Note 8 - Leases - Future Minimum Lease Payments for Financing Leases (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-8-leases-future-minimum-lease-payments-for-financing-leases-details Note 8 - Leases - Future Minimum Lease Payments for Financing Leases (Details) Details 44 false false R45.htm 044 - Disclosure - Note 9 - Concentrations (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-9-concentrations-details-textual Note 9 - Concentrations (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-9-concentrations 45 false false R46.htm 045 - Disclosure - Note 10 - Segment Information - Summary of Segment Information (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-10-segment-information-summary-of-segment-information-details Note 10 - Segment Information - Summary of Segment Information (Details) Details 46 false false R47.htm 046 - Disclosure - Note 11 - Disaggregated Net Revenues and Segment Information - Net Revenue, Classified by Geography (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-11-disaggregated-net-revenues-and-segment-information-net-revenue-classified-by-geography-details Note 11 - Disaggregated Net Revenues and Segment Information - Net Revenue, Classified by Geography (Details) Details 47 false false R48.htm 047 - Disclosure - Note 12 - Income Taxes (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-12-income-taxes-details-textual Note 12 - Income Taxes (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-12-income-taxes-tables 48 false false R49.htm 048 - Disclosure - Note 12 - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-12-income-taxes-significant-components-of-deferred-tax-assets-and-liabilities-details Note 12 - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) Details 49 false false R50.htm 049 - Disclosure - Note 12 - Income Taxes - Provision for Income Taxes (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-12-income-taxes-provision-for-income-taxes-details Note 12 - Income Taxes - Provision for Income Taxes (Details) Details 50 false false R51.htm 050 - Disclosure - Note 13 - Stock Based Compensation (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation-details-textual Note 13 - Stock Based Compensation (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation-tables 51 false false R52.htm 051 - Disclosure - Note 13 - Stock Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation-summary-of-stock-option-activity-details Note 13 - Stock Based Compensation - Summary of Stock Option Activity (Details) Details 52 false false R53.htm 052 - Disclosure - Note 13 - Stock Based Compensation - Unrecognized Compensation Costs (Details) Sheet http://www.admtronics.com/20200331/role/statement-note-13-stock-based-compensation-unrecognized-compensation-costs-details Note 13 - Stock Based Compensation - Unrecognized Compensation Costs (Details) Details 53 false false R54.htm 053 - Disclosure - Note 14 - Legal Proceedings (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-14-legal-proceedings-details-textual Note 14 - Legal Proceedings (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-14-legal-proceedings 54 false false R55.htm 054 - Disclosure - Note 15 - Subsequent Events (Details Textual) Sheet http://www.admtronics.com/20200331/role/statement-note-15-subsequent-events-details-textual Note 15 - Subsequent Events (Details Textual) Details http://www.admtronics.com/20200331/role/statement-note-15-subsequent-events 55 false false All Reports Book All Reports admt-20200331.xml admt-20200331.xsd admt-20200331_cal.xml admt-20200331_def.xml admt-20200331_lab.xml admt-20200331_pre.xml http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 71 0001437749-20-015110-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-015110-xbrl.zip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end